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ABSTRACT

PHYSIOLOGICAL RESPONSES TO FEEDING A YEAST CULTURE SUPPLEMENT
TO TRANSITION DAIRY COWS
NATHALY ANA CARPINELLI
2020
The transition period is the dynamic stage in the lactation cycle, where the most
metabolic changes can occur. The use of nutritional strategies, such as yeast culture, can
help cows during the transition from pregnancy to early lactation, improving health and
decreasing the incidence of metabolic disorders. The first objective of this research was
to evaluate the effects of a commercial yeast culture product (YC; Cellerate Culture Classic
HD, Phibro Animal Health, Teaneck, NJ) on performance, blood biomarkers, and rumen
fermentation and bacterial population in dairy cows during the transition period through 50
days in milk (DIM). Overall, the results showed that yeast culture products could promote
positive responses on performance, such as milk yield, somatic cell count (SCC), and
energy corrected milk (ECM). In the rumen, yeast culture product contributed to
increased valerate, which was accompanied by improvements in rumen bacteria
populations such as cellulolytic and lactic acid-utilizing bacteria. In addition, the results
suggest that yeast may influence lipid metabolism in transition dairy cows, based on
nonesterified fatty acid (NEFA) and beta-hydroxybutyrate (BHB) markers. The second
objective was to assess the effects of yeast-based products on metabolism, inflammation,
liver function, and immune function through blood biomarkers and gene expression in
polymorphonuclear leukocytes (PMNL) in dairy cows during the transition period until
50 DIM. Yeast supplementation might stimulate a mild inflammatory response in
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transition dairy cows, based on blood biomarker and PMNL mRNA expression. In
summary, we observed that yeast culture could promote improvements in performance,
rumen bacteria population, and stimulate the immune system in transition dairy cows
through 50 DIM.
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INTRODUCTION

The transition period is associated with the peak incidence of production
problems, metabolic disorders, and infectious diseases in dairy cows (Drackley, 1999).
During late pregnancy and particularly in early lactation, cows enter a condition called
negative energy balance (NEB) due to the increase in energy requirements. The NEB is
associated with a large mobilization of fatty acids stored in adipose tissue, thus, causing
marked elevations in blood concentrations of non-esterified fatty acids (NEFA) and βhydroxybutyrate (BHBA) (Drackley et al., 2006). Prolonged periods with high blood
NEFA and BHB concentrations in the bloodstream will eventually cause further
complications, such as metabolic disorders. In addition, during the transition period, the
cow’s immune system is suppressed. This is linked with the metabolic challenge
associated with the onset of lactation, which can affect the immune function.
The advancements in dairy cow nutrition enable the development of nutritional
strategies to help cows during the transition from pregnancy to early lactation. The
positive effects of yeast-based products from Saccharomyces cerevisiae in transition
dairy cows have been demonstrated (Dann et al., 2000; Yuan et al., 2015b; Olagaray et
al., 2019). The response to yeast supplementation has been reported to improve the
growth and activities of ruminal microbial communities and, consequently, promoting
positive effects on milk or meat production (Fonty and Chaucheyras-Durand, 2006).
Our general hypothesis is that yeast culture supplementation during the transition
period through 50 DIM will alleviate metabolic challenges associated with the onset of
lactation, and consequently improve health and performance in transition dairy cows. The
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objective of this study was to determine the effects a commercial yeast culture product
(YC; Cellerate Culture Classic HD, Phibro Animal Health, Teaneck, NJ) on health and
performance and correlate these with metabolism and immune function during the
transition period of dairy cows.
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CHAPTER 1. LITERATURE REVIEW
Transition period
Dairy cows have been genetically selected for the purpose of producing more
milk during their reproductive life. Because of this genetic selection, cows require
adequate management and nutrition during their reproductive life in order to sustain such
enhanced milk yield. In dairy cows, the transition period spans from 3 weeks before
through 3 weeks after parturition (Drackley, 1999), and it is the most critical period
during the cow’s life. It is characterized by dramatic changes in metabolism and
physiology, where most infectious diseases and metabolic disorders can occur (Grummer,
1995; Drackley, 1999). According to Trevisi and Minuti (2018), five critical points are
associated with the transition period: negative energy balance (NEB) due to the increase
in energy requirements and decrease in feed intake, which leads to mobilization of
adipose tissue; reduction of immune competence; systemic inflammatory condition;
oxidative stress; and hypocalcemia.
Physiology and metabolism
Negative energy balance
During late pregnancy and particularly in early lactation, the energy demands
increased in cows due to fetal development and milk production. At the same time, cows’
energy intake cannot meet those energy demands. A decline in energy intake is
commonly observed around parturition (Ingvartsen and Andersen, 2000). After
parturition, dry matter intake (DMI) tends to increase if the cow is healthy. However, the
health status will vary from cow to cow, which will be reflected in DMI. At the same
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time, major changes in metabolism are commonly reported in cows in order to cope with
the increase in nutrient requirements (Ingvartsen and Andersen, 2000).
Postpartum NEB is universal in mammals, and it is associated with an imbalance
between decreased energy intake and increased energy requirements for milk synthesis.
During this condition, cows mobilize large amounts of NEFA from adipose tissue to cope
with the energy deficit to sustain milk production (Ingvartsen and Moyes, 2013). Lipid
mobilization occurs when adipose tissue becomes predominantly lipolytic (Contreras and
Sordillo, 2011). This is a normal physiological adaptation due to the reduced energy
intake, coupled with an increase in energy demands after calving (Contreras and Sordillo,
2011).
Canonical metabolism
In early lactation, changes in endocrine signals and tissue metabolism have been
observed (Ingvartsen, 2006). The changes in tissue metabolism during the transition
period comprise liver, adipose tissue, and mammary gland. In adipose tissue, a lipolytic
state is predominant due to low insulin during NEB, while the liver needs to maintain
gluconeogenesis (Ingvartsen (2006). A summary of the metabolic adaptations across
adipose tissue, liver, and mammary gland during the peripartum is presented in Figure
1.1. During NEB, an increase in blood NEFA mobilization from adipose tissue is
commonly observed, which may exceed the capacity of the mammary gland to pack these
excess NEFA into milk (Drackley, 1999). The liver is the most important site to remove
and metabolize NEFA from circulation (Van den Top et al., 2005). During an extreme
rate of lipid mobilization, it will lead to increased uptake of NEFA by the liver (Drackley,
1999). Once taken up by the liver, NEFA can be 1) complete oxidized through the
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tricarboxylic acid cycle (TCA), providing energy for the liver; 2) partially oxidized to
ketone bodies, that will serve as an energy source for tissues; 3) TG synthesis for storage
in the liver; 4) TG synthesis to be exported into the bloodstream as a very-low density
lipoprotein (VLDL); 5) secreted in bile (Emery et al., 1992; Ingvartsen, 2006; White,
2015). Prolonged periods with high blood NEFA concentrations in the bloodstream will
eventually impair the liver’s ability to oxidize NEFA, causing further complications, such
as impaired liver function and fatty liver.
NEFA metabolism
Once in the liver, NEFA is converted to fatty acyl-CoA by the enzyme longchain-fatty-acid- acyl CoA synthetase. Fatty acyl-CoA is transported into the
mitochondria by the coordinated effort of carnitine palmitoyltransferase I (CPT-I) and II
(CPT-II) enzymes (Champe et al., 2005). Once inside the mitochondria, fatty acids (FA)
undergo β-oxidation (Ingvartsen, 2006). The enzyme CPT-I is located in the outer
mitochondrial membrane that converts fatty acyl-CoA in acylcarnitine that can be
transported over the internal mitochondrial membrane. Then, the acylcarnitine is
transported into the mitochondria by CPT-II, which converts acylcarnitine into fatty acylCoA that is oxidized via β-oxidation. The product of β-oxidation of fatty acyl-CoA is
Acetyl-CoA and can be further oxidized in the TCA cycle (Champe et al., 2005). In some
instances, the TCA cycle cannot oxidize the Acetyl-CoA generated via β-oxidation
product of low availability of TCA cycle intermediates such as oxaloacetate. In that case,
acetyl-CoA is then used to synthesize ketone bodies (Drackley, 1999). Ketone bodies
comprise acetoacetate (ACAC), BHB, and acetone (nonmetabolized product). The ACAC
and BHB are transported to peripheral tissues and can be used as an energy source.
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Excessive circulation of blood ketone bodies may negatively affect animal health and
performance, causing metabolic disorders such as ketosis (White, 2015).
In addition to mitochondrial β-oxidation of FAs, peroxisomal β-oxidation plays an
alternative role in FA oxidation when these are in excess in the liver (Ingvartsen, 2006).
The pathway is very similar to mitochondrial β-oxidation, except for the first step. The
initial oxidation is mediated by acyl-CoA oxidase, producing hydrogen peroxidase
(H2O2) instead of reduced NAD (Drackley, 1999). Although the peroxisome lacks of
respiration chain and the ability to produce ATP, its activity has been related to oxidative
stress and inflammation because of the production of H2O2, which is one of a family of
reactive oxygen species (ROS)(Champe et al., 2005). The peroxisomal β-oxidation of FA
is a significant source of ROS in transition dairy cows, however, most ROS found in
healthy tissues are a product of an increase in cellular metabolism and energy generation
by mitochondria (Drackley, 1999; Sordillo, 2016).
Fatty acids that are not oxidized are re-esterified with glycerol to form TG. A
portion of these TG is packaged into VLDL and exported into the bloodstream to be used
by extra-hepatic tissues (Champe et al., 2005). The mammary gland can use the FA
contained in VLDL for milk fat synthesis; however, these need to be uptaken with the
help of lipoprotein lipase, a VLDL receptor that hydrolyzes TG (Osorio et al., 2016). In
ruminants, it is well known that VLDL secretion is very limited (Grummer, 2008). The
low rate of synthesis and secretion of VLDL in ruminants is insufficient to remove
considerable amounts of accumulated TG in hepatocytes (Drackley et al., 2006). In
transition dairy cows, the low secretion of VLDL from liver could be explained by the
hepatic downregulation of mRNA expression of Apo-B100 (APOB, gene symbol),
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contributing to the accumulation of TG in liver (Bernabucci et al., 2004; Bernabucci et
al., 2009). Together, the oxidation of FAs, TG accumulation, and the low synthesis of
VLDL in the liver play a central role in the development of fatty liver syndrome
(Ingvartsen, 2006). The fatty liver syndrome implicates a limited capacity to secrete TG
within VLDL, coupled with an increased rate of FA esterification (McFadden, 2020).
According to Overton and Waldron (2004), almost all high-producing dairy cows
accumulate TG in liver during the first few weeks postpartum. Grummer (1993) observed
that fatty liver syndrome and ketosis are common metabolic disorders related to lipid
metabolism during the transition period.
Metabolic disorders
Fatty liver syndrome
The fatty liver syndrome is one of the major metabolic disorders that occur in the
peripartal dairy cow, compromising the cow’s metabolism (Bobe et al., 2004). White
(2015) described that during the transition between pregnancy and lactation, around 60%
of dairy cows develop fatty liver syndrome, which is a direct response to NEB. The rapid
decrease in prepartum DMI has been linked with greater postpartal lipid mobilization of
adipose tissue, increased NEFA, and accumulation of TG in liver (Drackley, 1999;
Grummer et al., 2004).
The fatty liver syndrome commonly occurs in the early postpartum period, when
an excess of TG accumulate in the liver. In dairy cows developing fatty liver syndrome,
the hepatic TG deposition is due to increased esterification of lipolytic-derived FA, and
the process is exacerbated by inadequate mitochondrial β-oxidation of FA (McFadden,
2020) or low production of VLDL to transport TG. The lipid accumulation causes
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significant alterations in the liver, affecting the normal hepatic function, cow’s health,
milk production, and reproductive performance (Bobe et al., 2004; White, 2015).
According to Grummer (2008), there are strategies that can be used to prevent or
treat fatty liver syndrome including: 1) decrease TG lipolysis in adipose tissue and, as a
consequence, reduced blood NEFA; 2) increase complete hepatic oxidation of NEFA; 3)
increase the rate of VLDL export from the liver. In this context, nutritional strategies
have been used to prevent fatty liver syndrome, such as adjustments on prepartal plane of
nutrition (Grum et al., 1996; Janovick et al., 2011; Osorio et al., 2013b), restricted diets
(Van den Top et al., 2005) and nutritional supplements (i.e., rumen-protected choline and
propylene glycol) (Grummer, 2008).
Ketosis
Ketosis is marked by an elevated circulation of ketone bodies associated with
increased NEFA infiltration in the liver. Peripheral tissues can be use ketone bodies as an
energy source; however, if the rate of ketones uptake by peripheral tissues is lower than
the hepatic ketone production, an increase in ketone bodies will be observed, also known
as hyperketonemia (Ingvartsen, 2006). Ketosis can be classified as a sub-clinical (SCK)
or clinical (≥1.4 mmol/L) based on blood BHB concentrations.
According to Oetzel (2004), cows with a clinical ketosis condition had higher
blood BHB concentrations (>3.0 mmol/L) than the BHB threshold used to determine
SCK. During SCK, it is observed an increase in blood, urine, or milk ketone bodies
without clinical symptoms; and in the clinical conditions, cows presented an increase in
blood, urine, or milk ketone bodies associated with clinical signs, such as inappetence,
weight loss, and dry manure (Gordon et al., 2013). The incidence of SCK varies widely
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across herds, but it has been reported to be around 60%, while clinical ketosis occurs
between 2% to 15% (Duffield, 2000). Ketosis or fatty liver syndrome conditions have
been negatively associated with immune function (Overton and Waldron, 2004). In a
review paper, Bobe et al. (2004) suggested that fatty liver syndrome is indirectly
associated with immune function because metabolic and hormonal changes attributed to
this syndrome may interfere with immune function. Ketosis is a metabolic condition that
can alter immune function in transition dairy cows (Zhu et al., 2019), regulate genes
involved in lipid metabolism (Mezzetti et al., 2019), impair liver function, and lead to
oxidative stress conditions (Rodriguez-Jimenez et al., 2018).
Immune system
The immune system comprises lymphoid organs, cells, and humoral factors that
work in a communicative network to recognize, resist, and eliminate pathogens (Bertoni
et al., 2015). The immune system is divided into innate and adaptive components, but
these two are integrated (Daha, 2011). The innate immunity is described by an early and
rapid response that can occur in seconds to combat a wide variety of potentially
infectious pathogens (Sordillo, 2016). In contrast, the adaptative immune system adapts
the response specifically to each infectious agent encountered and is delayed compared to
the innate immune system (Sordillo, 2016).
Innate immune system
The innate immune system is rapidly activated during the early stages of
infection. The major components of innate immunity include physical barriers, pattern
recognition receptors, complement activation, cytokines, oxylipids, endothelial cells, and
immune cells (Sordillo, 2016). The immune cells in the innate immune system are
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leukocytes [i.e., polymorphonuclear neutrophils (PMNL), monocytes, macrophages,
lymphocytes, eosinophils, basophils], dendritic cells, and natural killer cells. These cells
play an important role against pathogens as well as providing communication between
innate and adaptive immune systems.
The pattern recognition receptors (PRR) on the surface of the immune cells are
responsible for recognizing specific molecules on the surface of pathogens. These
receptors detect microbial factors associated with infectious pathogens and stimulate the
innate immune response (Sordillo, 2016). The PRR recognize two classes of
molecules: pathogen-associated molecular patterns (PAMPs) associated with pathogen
products; and damage-associated molecular patterns (DAMPs), which are related to host
cell components released during cell damage or death. This recognition by PRR stimulate
a number of responses, including cellular activity such as phagocytosis and initiation of
the inflammatory response (Trevisi and Minuti, 2018). For instance, toll-like receptors
(TLRs) recognize various PAMPs, which can initiate a signal pathway that induces gene
transcription and activation of inflammatory mediators, such as cytokines and
chemokines (Lee and Hwang, 2006). These mediators can affect endocrinal signals,
which coordinates an inflammatory response (Ballou, 2011).
During the early stages of the immune response, the goal is to localize and
eliminate the infection by recruiting immune cells, mainly neutrophils, to the site of
infection. The innate immune system combats 95% of infections through combined
mechanisms, including the action of different cell types (e.g., PMNL, monocytes,
macrophages), humoral factors (i.e., complement, lysozyme), and network of cytokines
(Daha, 2011).
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Neutrophils
Granulocytes are a subcategory of leukocytes, including PMNL, eosinophils, and
basophils, with different cytoplasmic characteristics and cellular morphologies. The
PMNL are the major circulating leukocytes (50-70%) and present cytoplasmatic granules
and multilobed nucleus that can be highly differentiated from the other leukocytes (Paape
et al., 2003). The PMNL cells are originated from myeloid lineage progenitor cells,
synthesized, and maturated in the bone marrow. The synthesis and maturation take
around 7 to 10 days until neutrophils release into the blood circulation (LeBlanc, 2020).
The PMNL circulate for a short time (6 to 8 h half-life in humans; 8.9 h in cows), but the
lifespan is extended once activated, although still to less than ∼1 day (Paape et al., 2003;
LeBlanc, 2020). A recent study in humans suggests that neutrophils may traffick through
more complex cycles and sites, and perhaps longer lifespans (Hidalgo et al., 2019). In
response to an infection, PMNL are considered the first line of defense from the innate
immune system against pathogens, mainly bacteria and virus. The inflammatory process
initiates with PMNL migrating to the site of infection. After migration, PMNL interact
with damaged cells or bacteria through a variety of mechanisms, including phagocytosis,
intracellular digestion by oxidation (e.g., oxidative burst in lysosomes), and extracellular
release of oxidants from neutrophil granules (e.g., myeloperoxidase) (LeBlanc, 2020).
Additionally, PMNL may undergo programmed apoptosis, culminating with casting
neutrophil extracellular traps (NETs) of DNA (LeBlanc, 2020).
The receptors in PMNL are classified according to their function, including
chemotactic, adhesion, cluster of differentiation (CD14), and opsonin receptors (Paape et
al., 2003). Chemotactic receptors are activated to recognize chemoattractants that recruit
PMNL to the site of infection. Examples of chemoattractants include chemokine (C-X-C
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motif) ligand 8 (CXCL8) (also called IL-8), platelet-activating factor, complement
component C5a, tumor necrosis factor α (TNFα), and PRR (Bassel and Caswell, 2018).
Adhesion receptors provide the attachment of PMNL to the endothelium and play an
important role in allowing PMNL to move across the endothelium adjacent to inflamed
tissue (Paape et al., 2003). L-selectin is one example of an adhesion receptor that
mediating the rolling of PMNL over the inflamed endothelium and subsequently
adherence (Raffler et al., 2005). The CD14 receptors bind bacterial toxins, such as
lipopolysaccharide (LPS) and cytokines that promote gene regulation related to the host
defense (Paape et al., 2003). Opsonin receptors are characterized by immunoglobulins
(e.g., IgM and IgG2) and complement components that promote bacteria recognition and
allow PMNL to initiate phagocytosis (Paape et al., 2003).
Pathogen recognition by neutrophils leads to phagocytosis, a process that involves
engulfing and killing pathogens. During the respiratory burst in PMNL, large volumes of
ROS (O2 and H2O2) are produced by stimulation of NADPH oxidase to destroy invading
pathogens (Sordillo et al., 2009). The accumulation of ROS can damage the host’s cells
and tissues and lead to oxidative stress in transition dairy cows. During the transition
period, the oxidative stress may be a major underlying cause of inflammatory and
immune dysfunction in dairy cattle, associated with parturition and a loss in antioxidant
potential (Sordillo and Aitken, 2009). In periparturient dairy cows, different variables can
affect neutrophil functional capacity. The main factors that influence neutrophil function
are fat mobilization (BHB, NEFA, oxidative stress), nutrient supply (antioxidant,
glucose, calcium), social stressors, and exogenous immune modulators (LeBlanc, 2020).
In addition, mRNA expression has been correlated with neutrophil function (Moyes et al.,
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2014; Batistel et al., 2017; Vailati-Riboni et al., 2019). Metabolic status alters the
expression of genes associated with inflammation in bovine blood PMNL (Moyes et al.,
2010).
Macrophages
Premonocytes are synthesized in the bone marrow and released into the
bloodstream, where they differentiate in monocytes (MO) and have a half-life of 1-2 d
(Ziegler-Heitbrock, 2014). Once in the bloodstream, they can migrate into the tissues and
differentiate into tissue-specific macrophages, such as intestinal macrophages (gut),
osteoclasts (bone), kupffer cells (liver), and adipose tissue macrophages (adipose tissue).
Macrophages form a line of defense in tissues, like a barrier against infection. Important
functions of macrophages and monocytes include phagocytosis, ROS production, and
secretion of pro-inflammatory cytokines during an inflammatory response (Calder, 1995).
Macrophages are involved in the innate and adaptative immune responses because they
can also behave as antigen-presenting cells, recruiting other immune cells to the site of
infection through antigen presentation to T cells (Calder, 1995).
In transition dairy cows, adipose tissue macrophages (ATM) are a key component
during lipolysis in adipose tissue due to NEB. During lipolysis, the role of ATM is to
remove lipolytic products (e.g., FA, diglycerides, and monoglycerides), recruitment of
new adipocyte progenitors by secreting chemotactic proteins, and activation of NF-κB
transcription factor pathways and inflammatory gene transcription (Contreras et al.,
2017).
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Lymphocytes
Lymphocytes are produced in the bone marrow and newly release lymphocytes
are termed naïve, virgin, or unprimed. They become activated due to local antigenic
stimulation responses and are termed memory or effector cells (Sordillo and Streicher,
2002). Lymphocytes consist of T cells (helper or cytotoxic) and B cells (secrete
antibody). The T cells can be subdivided into T-helper and T-cytotoxic (CTL)
lymphocytes. The T-helper cells produce cytokines, such as interleukin-2 (IL-2) and
interferons (IFN), crucial for an effective cell-mediated immune response. The B
lymphocytes differentiate to produce proteins called antibodies or immunoglobulins (Ig)
and effector B cells or plasma cells (Sordillo et al., 1997). Plasma cells are central to
specific immunity, which have a short half-life and produce and secrete antibodies.
The innate immune system in transition dairy cows
Peripartal dairy cows are often regarded as immunocompromised animals because
functions related to the immune system seem to be depressed. In a recent review paper,
Trevisi and Minuti (2018) reported that peripartal cows have a high probability of
experiencing events that challenge their immune system and expose any
immunocompetence. Such effects are related to the NEB characterized by critical
reduction of feed intake around parturition, severe body fat mobilization, production of
ROS, and incidence of metabolic disorders.
Before calving, the immune dysfunctions can be due to a combination of
metabolic and endocrine factors. However, it is not clear if the reduction in
immunocompetence is a physiological condition of transition dairy cows or an early
signal of disease induced by other events (Trevisi and Minuti, 2018). It is well established
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that some cellular processes essential in the immune system are depressed around
calving, including phagocytosis by neutrophils, antibody synthesis by lymphocytes, and
immunoglobulins concentration in plasma (Goff and Horst, 1997; Lacetera et al., 2005;
Trevisi and Minuti, 2018). After parturition, the development of health disorders, such as
mastitis, ketosis, retained placenta, metritis, and displaced abomasum, can contribute to
immune dysfunction (Sordillo, 2016). In addition, metabolic changes related to energy
and calcium supply in support of lactation can also impair the innate immune system
(Ingvartsen and Moyes, 2013).
Immune dysfunction has been correlated with specific factors associated with the
transition period. For example, after calving, blood glucose is prioritized to the noninsulin-dependent glucose transporters, which are only expressed on immune cells and
the mammary gland. This is particularly important during systemic inflammation when
activated immune cells have higher glucose requirements to sustain phagocytic and
killing capacity (i.e., oxidative burst) activities (Kvidera et al., 2017). Changes in steroid
hormones can contribute to an immune dysfunction during the transition period, mainly
by altering the function of neutrophils (Sordillo and Mavangira, 2014). Glucocorticoids
are known to have a potent immunosuppressive effect on blood neutrophil, while
prepartal estradiol and progesterone were reported to affect the functional capabilities of
immune cells (Sordillo and Mavangira, 2014).
Inflammatory response during the transition period
The inflammatory response comprises localized and systemic responses that
involve physiological and pathological alterations that help the body adapt or eliminate
adverse stimulus to return tissues to normal function or homeostasis (Bradford et al.,
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2015; Sordillo, 2016). The most common event to occur during the inflammatory
responses is a systemic or acute phase response (APR). The mechanisms include fever,
pain, leukocytosis, and the over- or under-expression of a large family of structurally
unrelated proteins, the acute phase proteins (APP) (Ceciliani et al., 2012).
The liver plays an important role during APR, coordinating the synthesis of key
metabolites to face an inflammatory condition. The primary stimulators of the APR are
the pro-inflammatory cytokines, including TNFα, IL1β, and IL6 (Gauldie et al., 1987).
These cytokines can activate leukocytes and endothelial cells (Bannerman et al., 2009)
and alter the normal synthesis of proteins in hepatocytes. These proteins for which their
hepatic synthesis is affected during APR are called acute phase proteins (APP). The APP
play major roles during APR, and they are classified as positive (increase) or negative
(decrease) APP depending on their change in blood concentration over the course of an
inflammatory condition (Ceciliani et al., 2012). The blood concentration of positive APP
increases during inflammation, and haptoglobin, serum amyloid A, LPS binding protein,
ceruloplasmin, and fibrinogen are common examples of positive APP. Oppositely,
negative APP includes paraoxonase, albumin, lipoprotein, and retinol binding protein.
As mentioned previously, the peripartal dairy cow is an immunocompromised animal
characterized by inflammatory conditions such as infectious diseases and metabolic
disorders that often result in pro-inflammatory cytokine release, e.g., TNFα, IL1β, and
IL6 (Bertoni et al., 2008). In turn, any significant increment in the severity or length of
exposure time to these pro-inflammatory cytokines will likely induce a change in the
hepatic activity related to the synthesis of APP.
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Nutritional strategies during the transition period
In past years, valuable information about the condition of cows undergoing the
transition from pregnancy to early lactation has been reviewed, including nutritional and
management approaches to minimize the incidence of postpartal metabolic and
reproductive related diseases (Drackley, 1999; Ingvartsen, 2006; Sordillo, 2016).
Prepartal DMI has a major effect on postpartal DMI and peripartal lipid metabolism,
which, in turn, influence the incidence of health disorders (Drackley, 1999). Ingvartsen
(2006) reported a link between body fatness at calving and subsequent degree of lipid
mobilization, underscoring the importance of managing dairy cows to calve at the
optimum body fatness to decrease the risk of developing health disorders. Later, Sordillo
(2016) focused more on the connection between nutritional strategies and the immune
system, suggesting that the development of nutritional-based strategies that can enhance
the immune response will have a prominent role in food animal agriculture.
Dairy cattle research has demonstrated the potential of nutritional strategies such
as manipulation of prepartal energy intake (Grum et al., 1996; Janovick et al., 2011; Zhou
et al., 2015), supplementation with amino acids (Osorio et al., 2013a; Zhou et al., 2016;
Abdelmegeid et al., 2018), and yeast-based products (Zaworski et al., 2014; Yuan et al.,
2015b; Stefenoni et al., 2020) to improve the health as well as preventing metabolic and
reproductive disorders in transition dairy cows.
Yeast-based products
Yeast-based products have been used in livestock animals for many years due to
its beneficial effects, with the most common yeast species being Saccharomyces
cerevisiae. The effects of yeast products in ruminants have been previously reviewed
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from rumen characteristics and animal performance point of view (Fonty and
Chaucheyras-Durand, 2006; Chaucheyras-Durand et al., 2008). Among the main effects
observed, yeast improves growth and activities of ruminal microbial communities and,
consequently, promotes positive effects on milk or meat production (Fonty and
Chaucheyras-Durand, 2006). Yeast can be beneficial to balance digestive microflora,
promoting better animal health (Chaucheyras-Durand et al., 2008). However, the use of
yeast appears to be more relevant when both animal and its rumen microbiota are
challenged, for example, during a sudden nutritional change or stress period
(Chaucheyras-Durand et al., 2008). Furthermore, yeast-based products from S. cerevisiae
are commercially available in different forms: live, dead, a combination of both forms
(live and dead), or yeast culture.
Yeast culture
Yeast culture is a complex fermentable yeast-based product that contains yeast
biomass and fermentation metabolites, including vitamins, proteins, peptides, amino
acids, nucleotides, lipids, organic acids, oligosaccharides, esters, and alcohols (Jensen et
al., 2008). Yeast culture can also provide fermentable metabolites, minerals, and enzymes
that can change the profile and physiology of ruminal bacteria (Chaucheyras-Durand et
al., 2008; Ghazanfar et al., 2017). In addition, yeast culture may contain residual amounts
of yeast biomass, providing mannooligosaccharides and glucans, which can promote an
immunomodulatory effect (Jensen et al., 2008).
Main effects and mode of action of yeast-based products
Several mechanisms have been proposed to explain the mode of action of yeast in
animal nutrition; however, the overall positive effect is the modulation and improvement
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of the rumen microbial population. The main factors implicated in the beneficial effects
of yeast are 1) oxygen uptake; 2) micronutrient supply; and 3) ruminal lactate
metabolism; that will promote microbial establishment (Chaucheyras-Durand et al.,
2008). Figure 1.2 summarizes the mode of action of yeast products at the rumen and
animal level.
Live yeast can scavenge oxygen, and as a result, promote a better anaerobic
ruminal environment. Live yeast can interact with ruminal bacteria in a “microconsortium structure”, by promoting a localized anaerobiosis in freshly ingested particles
(e.g., forages and starch) that may contain oxygen, thus benefiting bacterial digestion
(Jouany, 2006). Live yeast uses oxygen to metabolize sugars and oligosaccharides, which
results in end-products (e.g., ethanol, glycerol, and peptides) utilized by ruminal bacteria
to stimulate growth and fermentation (Jouany, 2006; Ghazanfar et al., 2017). The
anaerobic environment promoted by live yeast improves growth and metabolism of
cellulolytic species, given their high sensitivity to the presence of oxygen (ChaucheyrasDurand and Fonty, 2009; Ghazanfar et al., 2017). Oxygen scavenging by live yeast can
increase cellulolytic bacteria populations and the flow of microbial protein to the lower
gastrointestinal tract, which will contribute to the metabolizable protein (Fonty and
Chaucheyras-Durand, 2006). In support of the oxygen uptake theory, Newbold et al.
(1996) reported that wild-type strains of S. cerevisiae were able to consume oxygen and
stimulate bacterial activity in rumen-simulating fermenters. Lactate can accumulate
rapidly in the rumen due to sudden changes to high carbohydrate diets. Volatile fatty
acids (VFA) are one the end-products of ruminal fermentation. Lactate is considered a
stronger acid than VFA (pKa 3.9 versus 4.7, respectively), and the accumulation of lactate
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in rumen can lead to a more pronounced decrease in pH (Russell, 2002). The decrease in
pH can render cows at risk of developing subacute ruminal acidosis (SARA). The effect
of yeast supplements on maintain ruminal pH and preventing SARA has been attributed
to a reduction in ruminal lactate production (Dias et al., 2018) while stimulating growth
of lactate-utilizing bacteria (Callaway and Martin, 1997; Fonty and Chaucheyras-Durand,
2006). Lactate-associated bacteria such as Megasphaera elsdenii, Anaerovibrio
lipolytica, and Selenomonas ruminantium can utilize lactate as an energy source and
produce a variety of end-products (Russell, 2002; Puniya et al., 2015). The lactate
reduction caused by yeast supplementation has been reported by Pinloche et al. (2013),
who demonstrated that live yeast supplementation was associated with greater lactateutilizing bacteria. This, in turn, promoted greater total VFA and ruminal pH while
reducing lactate. In addition, the increase in lactic acid utilizer bacteria has been
associated with better animal efficiency due to its metabolic pathway that utilizes lactate
to produce propionate (Pinloche et al., 2013; AlZahal et al., 2014; Shabat et al., 2016).
Taking together, the effects of live yeast on oxygen uptake, micronutrient supply,
and pH stabilization may depend on the type of yeast or the diet of the animals. However,
most of the yeast products can stabilize rumen pH (Desnoyers et al., 2009) by promoting
an increase in cellulolytic (Fibrobacter and Ruminococcus) and lactate-utilizing bacteria
(Megasphaera and Selenomonas) (AlZahal et al., 2014; Jiang et al., 2017b). Little is
known about the positive effects of yeast-based products on the immune system in dairy
cows. The effects of yeast cell wall components such as β-glucans and
mannooligosaccharides have been reported as the main mechanisms to interact with the
immune system. This has been well established since these two yeast cell wall
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components can promote an immunomodulatory response (Goodridge et al., 2009;
Korolenko et al., 2019). The β -glucan can activate macrophages, dendritic cells,
neutrophils, natural killer cells, B and T lymphocytes, and increase phagocytosis and
cytokine production (Kim et al., 2011). Mannooligosaccharides can regulate the
inflammatory response by modulating the level of molecules released into the circulation
during inflammation (Korolenko et al., 2019). Yeast can modulate gene expression in
porcine intestinal epithelial cells, by decreased the transcript and protein abundance of
pro-inflammatory genes, including IL-6 and IL-8, during Escherichia coli exposure
(Zanello et al., 2011).
The mechanism behind the interaction between supplemented yeast, rumen
epithelium, and innate immunity still unclear. This interaction can be partially attributed
to better energy status promoted by positive effects on digestion or activation of the
immune system by sensing yeast components (Lopreiato et al., 2020). A recent in vitro
study using ovine ruminal epithelial cells demonstrated that β-glucan could activate the
immune system via Dectin-1 signaling pathway, suggesting a potential mechanism to
explain this activation (Zhang et al., 2019). This mechanism was explained by β-glucan
from S. cerevisiae upregulating β-defensin 1 (SBD1) in ovine ruminal epithelial cells via
the Dectin-1–Syk–NF-κB axis, which can release a variety of cytokines, thereby
promoting the innate immune function. Similar to β-glucan, the effects of mannan
derived from S. cerevisiae have been reported in ovine cell culture models. For instance,
mannan can induce β-defensin-1 expression via Dectin-2-Syk-p38 pathway in ovine
ruminal epithelial cells (Jin et al., 2019). According to these findings in vitro, the immune
activation by β-glucans and mannooligosaccharides in ovine ruminal epithelial cells is
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due to the C-type lectin receptor involved in fungal recognition (Jin et al., 2019; Zhang et
al., 2019). To our knowledge, there are no studies evaluating C-type lectin receptor on
ruminal epithelium or immune cells in transition dairy cows. In transition dairy cows,
Bach et al. (2018) reported that live yeast supplementation resulted in upregulation of
genes (e.g., TLR4) related to inflammation and epithelial barrier in the ruminal
epithelium, leading to a quicker response by innate and adaptive immunity.
Yeast-based products in dairy cow performance
In dairy cows, the effects of different yeast products have been reported across
performance (Jiang et al., 2017a; Dias et al., 2018), rumen characteristics (AlZahal et al.,
2014; Jiang et al., 2017b; Zhu et al., 2017) and methane emission (Meller et al., 2019;
Welty et al., 2019). However, there is a lack of consistency in response to yeast
supplementation in dairy cows, which might be associated with the wide variety of
configurations of yeast products and metabolites that can be incorporated in animal feeds.
In addition, Piva et al. (1993) suggested that the stage of lactation, type of forage, feeding
strategy, and the forage-to-concentrate ratio can affect the response to yeast
supplementation in dairy cows.
In a meta-analysis Robinson and Erasmus (2009) examined 22 lactation
experiments with different S. cerevisiae-based yeast products and observed a 0.9 kg/d
increase in milk production due to yeast supplementation. Desnoyers et al. (2009)
summarized the findings from 110 papers and 157 experiments in ruminants, representing
a broad range of yeast products and feeding conditions, reporting effects of yeast
supplementation on dry matter intake, milk yield, rumen pH, rumen VFA, and organic
matter digestibility. In a more recent meta-analysis, Poppy et al. (2012) reported that
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yeast culture from S. cerevisiae could increase milk yield, milk fat, and milk protein in
dairy cows. In the same meta-analysis, it was observed that yeast culture supplementation
during early lactation increased DMI by 0.62 kg/d and energy-corrected milk (ECM) by
1.65 kg/d.
Yeast-based products in peripartal dairy cows
Live yeast or yeast-based products supplementation has been evaluated in
peripartal or early lactation dairy cows in terms of performance (Dann et al., 2000; Nocek
et al., 2011; Shi et al., 2019; Stefenoni et al., 2020), rumen characteristics (Al Ibrahim et
al., 2010; Bach et al., 2019), metabolic profile (Zaworski et al., 2014; Faccio-Demarco et
al., 2019; Olagaray et al., 2019) and immune system function (Yuan et al., 2015b;
Knoblock et al., 2019).
Dann et al. (2000) observed that yeast culture improved DMI during the last 7 d
before calving through the first 42 d of lactation, suggesting a potential benefit to the
common decline in DMI during the transition period. Later, Shi et al. (2019) also
observed effects on DMI, where the use of yeast culture increased feed intake around
calving and feed efficiency postpartum. In early lactation dairy cows, yeast culture plus
enzymatically hydrolyzed yeast improved production performance and mammary gland
health (Nocek et al., 2011). In a recent study, Stefenoni et al. (2020) described that the
use of yeast culture plus enzymatically hydrolyzed yeast did not affect DMI or milk
production; however, they observed positive effects on milk components coupled with a
decrease in days to first estrus. In contrast, other experiments did not observe
improvements in performance, using live yeast or yeast culture (Al Ibrahim et al., 2010;
Olagaray et al., 2019).
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During the peripartal period, the rumen experiences a transient but important loss
of microbial diversity, followed by a recolonization process due to diet, physiological,
and environmental changes (Bach et al., 2019). The recolonization process occurs after
calving, and it is characterized by a shift in bacterial populations that will affect the
rumen kinetics and VFAs profile (Minuti et al., 2015). In addition, Minuti et al. (2015)
observed changes in rumen characteristics, such as increased butyrate and decreased
ruminal pH and acetate, which were partially explained by alterations in ruminal
microbial species. Such alterations corresponded to increased Anaerovibrio lipolytica,
Prevotella bryantii, and Megasphaera elsdenii, while decreased fibrolytic bacteria
(Fibrobacter succinogenes and Butyrivibrio proteoclasticus). Al Ibrahim et al. (2010) did
not observe major alterations in rumen parameters due to live yeast supplementation;
however, they observed an increase in rumen protozoal counts, acetate molar proportion,
and a reduction in rumen ammonia. In a recent study focused on rumen microbiota, Bach
et al. (2019) reported that most of the effects of live yeast supplementation on rumen
population were observed before calving and the taxonomic diversity after calving was
more associated with feed intake, milk yield, and feed efficiency.
Metabolic shifts during the transition period are common because of the
adaptations associated with the transition period, such as NEB, reduced
immunocompetence, and systemic inflammatory condition. Yeas culture supplementation
can decrease serum cortisol concentrations and tended to increase serum concentrations
of calcium, glucose, urea, and serum amyloid A during the first day after calving
(Zaworski et al., 2014). This suggests that yeast culture may affect the metabolic and
immunologic status of dairy cows in early lactation. Recent findings reported that yeast
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culture supplementation led to shifts in cholesterol metabolism, tending to decrease
hepatic cholesterol and increase plasma cholesterol (Olagaray et al., 2019), while other
studies did not report the same effects (Piva et al., 1993). In a semi-extensive production
system, supplementation with yeast culture plus enzymatically hydrolyzed yeast had no
impact on the metabolic profile of dairy cows, even when these cows produced more
milk (Faccio-Demarco et al., 2019).
The connections between the ruminal effects of yeast products and subsequent
systemic responses (e.g., immunometabolism) in transition dairy cows remain unclear.
Yuan et al. (2015b) reported that yeast culture plus enzymatically hydrolyzed yeast
supplemented at rates of 0, 30, 60, or 90 g/d from -21 to 42 d relative to calving linearly
increased plasma anti-ovalbumin IgG levels following 3 ovalbumin challenges, which, in
turn, indicates enhanced humoral immunity. Yuan et al. (2015b) also suggested that yeast
supplementation in transition dairy cows could enhance mucosal immunity. Together,
these effects could modulate uterine inflammatory signals and mammary gland health.
Recently, Knoblock et al. (2019) reported the effects of yeast culture supplementation in
dairy cows fed either a low-starch (22.1% starch) or high-starch (28.3% starch) diets
during early lactation. They observed that yeast culture supplementation had an antiinflammatory effect, indicated by the lower serum haptoglobin, but no effects on adaptive
immunity were detected. Knoblock et al., 2019 also concluded that a combination of
yeast culture and low-starch diets during early lactation might reduce inflammation. In
lactating dairy cows, yeast cell wall supplementation could increase mRNA expression of
cytokines in peripheral blood mononuclear cells and enhance immune function (Aung et
al., 2020).
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RATIONALE AND OBJECTIVES
The overall goal of this study was to understand the physiological responses to
feeding a yeast culture supplement to transition dairy cows. Therefore, the objectives of
this study were to evaluate the effects of a commercial yeast culture product on a)
performance, blood biomarkers, rumen fermentation, and bacterial population; b)
metabolism, inflammation, liver function, and immune function through blood
biomarkers and gene expression in PMNL.

CONCLUSION
The success of the transition period will determine the profitability of the cow
during that lactation (Drackley, 1999). Adequate nutrition and good management
practices are essential for a successful transition period in dairy cows (Drackley et al.,
2006). The transition period is commonly associated with metabolic and immunologic
challenges. For instance, factors associated with NEB, such as the rapid decrease in DMI
before parturition and lipid mobilization from adipose tissue, are important points to
consider when designing a dry cow management. During early lactation, cows are more
susceptible to develop metabolic disorders, and the approaches of management should
focus on it.
Nutritional approaches have been developed through research to help cows
achieve a smooth transition between late pregnancy to lactation. The interest in using
yeast-based products derived from S. cerevisiae in dairy cows’ rations has increased in
recent years. The utilization of these products appears to be relevant to improve
performance and health. Yeast products are commercially available in different forms,
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such as live, dead, a combination of both (live and dead), or yeast culture. Various
mechanisms have been proposed to explain the mode of action of yeast in animal
nutrition; however, the overall positive effect is the modulation and improvement of the
rumen microbial population. The main factors implicated in the beneficial effects of yeast
are 1) oxygen uptake; 2) micronutrient supply; and 3) ruminal lactate metabolism; that
will promote microbial establishment (Chaucheyras-Durand et al., 2008). Besides the
ruminal effects of live yeast, yeast cell wall components can be highly degradable in the
rumen and promote an immunomodulatory effect (Jensen et al., 2008).
Based on the above, the use of alternative nutritional strategies, such as yeast
culture, can promote beneficial effects in dairy cows, especially during stressful periods
such as the peripartal period. However, the optimal utilization of yeast-based products to
confer the best physiological conditions to dairy cows for a smooth transition from
pregnancy to lactation remains to be elucidated. The extensive amount of research and
plethora of commercial yeast products and their combinations highlights the tremendous
potential of yeast to fine-tune the metabolism and immune system of livestock animals. If
decipher correctly, yeast technology applied to solve the inheritely complex
immunometabolic challenges in the transition dairy cow model will provide the largest
gains in productivity and profitability in commercial dairy farms.
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Figure 1.1 - Schematic representation of relationships among lipid metabolism in adipose
tissue, liver, and mammary gland. Plus signs (+) indicate stimulatory effects, minus signs
(−) indicate inhibitory effects. Dashed lines indicate processes that occur at low rates or
only during certain physiological states. Abbreviations: Epi = epinephrine, NEFA = nonesterified FAs; TG = triglyceride, VLDL = very-low-density lipoproteins. Source: Adapted
from (Drackley, 1999).
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Figure 1.2 - Schematic representation to explain the action of yeast in the rumen. Adapted
from (Jouany, 2006, Chaucheyras-Durand et al., 2008).
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CHAPTER 2. EFFECTS OF FEEDING YEAST CULTURE PRODUCT ON
PERFORMANCE, BLOOD BIOMARKERS, RUMEN FERMENTATION, AND
RUMEN BACTERIA SPECIES IN PERIPARTAL DAIRY COWS

ABSTRACT
Feeding yeast culture fermentation products has been associated with improved
feed intake and milk yield in transition dairy cows. The objective of this study was to
evaluate the effects of a commercial yeast culture product (YC; Culture Classic HD; Phibro
Animal Health, Teaneck, NJ) on performance, blood biomarkers, rumen fermentation and
bacterial population in dairy cows during the transition period until 50 DIM. Forty Holstein
dairy cows were enrolled in a randomized complete block design from -30 to 50 DIM and
blocked according to expected calving day, parity, previous lactation milk yield, and
genetic merit. At -30 DIM, cows were assigned to either a basal diet plus 114 g/d of
ground corn (CON; n = 20) or basal diet plus 100 g/d of ground corn and 14 g/d YC (n =
20), fed as a top-dress. Cows received the same close-up diet from -30 until calving (1.39
Mcal/kg DM and 12.3% CP) and lactation diet from calving to 50 DIM (1.60 Mcal/kg
DM and 15.6% CP). Blood samples and rumen fluid were collected at various time points
from -30 to 50 d relative to calving. Cows fed YC compared with CON had trend for an
increased milk yield (+2.5 kg/d) and ECM (+3.2 kg/d). Lower SCC was observed in YC
cows than CON. There was a diet × time interaction in NEFA and BHB that could be
attributed to a trend for greater NEFA and BHB in YC cows than CON at 7 DIM,
followed by a lower NEFA in YC cows than CON at 14 and 30 DIM. Similarly, BHB
tended to be lower in YC cows than CON at 30 DIM. This suggests yeast
supplementation have a potential effect on postpartal metabolism. In the rumen, YC
product contributes to mild changes in rumen fermentation, mainly increasing postpartal
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valerate while decrease isovalerate. This was accompanied by alterations in rumen
microbiota, including a greater abundance of cellulolytic (Fibrobacter succinogenes) and
lactate-utilizing bacteria (Megaspheara elsdenii and Anaerovibrio lipolytica). These
results show an overall beneficial effect of supplementing yeast culture during the late
pregnancy through early lactation, at least in terms of rumen environment and
performance.
Key words: transition cow, yeast culture, rumen bacteria

INTRODUCTION
The transition period has been defined as a critical period for dairy cows,
characterized as 3 wk before and 3 wk after parturition (Drackley, 1999). This is a
challenging period for dairy cows because of the lactogenesis, uterine involution, and
metabolic and endocrine changes associated with negative energetic balance (Bradford et
al., 2015) and often impairs the immune response (Trevisi and Minuti, 2018). Direct-fed
microbials can be used as a nutritional alternative to improve health and performance
during the transition between pregnancy and early lactation (Roche et al., 2013; Lopreiato
et al., 2020).
Yeast culture is a complex fermentable feed additive that contains: yeast cell walls
(i.e., beta-glucans and mannan-oligosaccharides), vitamins, proteins, peptides, amino
acids, nucleotides, lipids, organic acids, oligosaccharides, esters, and alcohols (Jensen et
al., 2008). According Chaucheyras-Durand et al. (2008), the main effects of yeast products
are related to rumen fermentation, benefiting key microbial populations and their
metabolism, and consequently increasing fiber degradation and stabilizing rumen pH.

32

The beneficial effects of different live yeast or yeast culture-based products have
been reported on the performance of dairy cows supplemented throughout the transition
period or during early lactation only (Dann et al., 2000; Nocek et al., 2011; Shi et al., 2019).
These effects have been further described in terms of rumen characteristics (Al Ibrahim et
al., 2010; Bach et al., 2019), metabolic profile (Zaworski et al., 2014; Faccio-Demarco et
al., 2019; Olagaray et al., 2019) and immune system function (Yuan et al., 2015b;
Knoblock et al., 2019; Lopreiato et al., 2020). However, these cumulative data on yeast
supplementation across transition cow studies are inconsistent and might be associated with
the wide variety of configurations of yeast cultures or yeast fermentation metabolites used
in such studies.
The yeast culture evaluated in the current study was a concentrated form of yeast
culture and fermentation metabolites originating from a S. cerevisiae yeast strain that is
grown on a medium and dried on beneficial plant-based carriers. The hypothesis was that
feeding this complex product during the transition period would affect performance and
ruminal characteristics. The objective of this study was to evaluate the effects of a
commercial yeast culture product (Cellerate Yeast Solutions®, Culture Classic HD; Phibro
Animal Health, Teaneck, NJ) on performance, blood biomarkers, rumen fermentation, and
bacterial population in dairy cows during the transition period until 50 DIM.

MATERIAL AND METHODS
Experimental Design and Dietary Treatments
The Institutional Animal Care and Use Committee (IACUC) of the South Dakota
State University approved all the procedures for this study. Forty late pregnant Holstein
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dairy cows, including 34 multiparous and 6 primiparous cows, were used in a randomized
complete block design and were blocked according to calving day, parity, previous
lactation milk yield, and genetic merit.. During the dry period, the cows received the
same close-up diet (1.39 Mcal of NEL/kg and 12.3% CP; Table 2.1) and at -30 d before
expected calving date cows were assigned to the treatments. The treatments were topdressed as a control (CON; 114g/h/d ground corn; n = 20) or CON plus Culture Classic
HD (YC; 100 g ground corn + 14g YC/h/d; n = 20). After parturition, all cows were fed
the lactation basal diet (1.60 Mcal of NEL/kg and 15.56% CP; Table 2.1), as a total mixed
ration, and the supplementation continued through 50 d postpartum.
Animal Management
Cows were enrolled in the experiment from mid-September 2018 to early April
2019. Cows were fed using an individual gate system (American Calan, Northwood,
NH), and intakes were recorded daily. Diets were formulated using the NDS Professional
(Nutrition Dynamic System; RUMN Sas.) to meet requirements of the average cow in
the group according to the NRC (2001) (Table 2.1). Dry matter (DM) of individual feed
ingredients was determined weekly and diets were adjusted accordingly to maintain
formulated DM ratios of ingredients in the total mix ratio (TMR). The cows were fed
once daily before morning milking using a Data Ranger Tool
(http://americancalan.com/code/template.cfm?page=3). The feed offered was adjusted
daily to achieve a 5 to 10% refusals the following days.
During the dry period, cows were housed in a bedded pack pen, and 3 d before
expected calving date, cows were reallocated in individual pens bedded with straw until
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parturition. On day 3, after calving, cows were moved to a lactation free-stall barn where
they were receiving the same lactation basal diet until 50 d postpartum.
Body weight was measured weekly for each cow in the afternoon at 13:00h. Body
condition score (BCS) (scale 1= thin to 5= obese) was assigned by two individuals and
the average score was used for statistical analysis.
Feed and Milk Samples
Individual samples of ingredients and TMR were collected weekly were frozen at
-20°C after DM analysis and until further nutrient analysis. Composited samples for
ingredients and TMR were analyzed for contents of DM, CP, NEL, NDF, ADF, using wet
chemistry methods (Dairy One, Ithaca, NY).
Cows were milked twice a day and milk yield was recorded at each milking until
50 DIM. Consecutive morning and evening milk samples were collected 1 d/wk

during

the experimental period. Composite milk samples were performed in proportion to milk
yield at each milking, preserved (Broad Spectrum Microtabs II, Advanced Instruments,
Norwood, MA), and analyzed for fat, protein, lactose, solids, milk urea nitrogen (MUN)
and somatic cell count (SCC).The ECM was calculated based on milk yield and milk
sample analysis as follows: ECM = [12.82 × fat yield (kg)] + [7.13 × protein yield (kg)] +
[0.323 × milk yield (kg)] (Hutjens, 2010). Equations from NRC (2011) were used to
calculate energy balance (EB) for each cow. The energy intake was determined using
daily DMI multiplied by NEL density of the diet. Net energy of maintenance was
calculated as BW0.75 × 0.080. Requirements of NEL were calculated as NEL = (0.0929 ×
fat % + 0.0547 × protein % + 0.0395 × lactose %) × milk yield. The net energy
requirement for pregnancy (NEP; Mcal/d) was calculated as NEP = [(0.00318 × day of
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gestation − 0.0352) × (calf birth weight/45)]/0.218. The equation used to calculate
prepartal EB (EBPRE; Mcal/d) was EBPRE = NEI − (NEM + NEP) and EBPRE (as % of
requirements) = [NEI/ (NEM + NEP)] × 100. The equation used to calculate postpartal EB
(EBPOST) was EBPOST (Mcal/d) = NEI − (NEM + NEL) and EBPOST (as % of requirements)
= [NEI/(NEM + NEL)] × 100.
Blood Collection and Analyses
Blood was sampled from the coccygeal vein before morning feeding using a 20gauge vacutainer needle (Becton Dickinson, Franklin Lakes, NJ) at -30, -15, 7, 14, and 30
d relative to parturition from a subset of multiparous cows (n=8 multiparous
cows/treatment). Blood was collected into evacuated tubes (5 mL, BD Vacutainer,
Becton Dickinson, Franklin Lakes, NJ) containing either serum clot activator or lithium
heparin. After collection, tubes that contained lithium heparin were placed on ice and
tubes with serum clot activator were kept at 21°C until centrifugation. Serum and plasma
were obtained by centrifugation at 1,300 × g for 15 min at 21°C and 4°C, respectively.
The aliquots of plasma were frozen at -80°C until further analysis.
Plasma samples were analyzed for biomarkers of muscle body mass [e.g.,
creatinine and urea], metabolism [e.g., glucose, NEFA and BHB] and oxidative stress
[e.g., reactive oxygen metabolites (ROM) and ferric reducing anti-oxidant power
(FRAP)] using kits purchased from Instrumentation Laboratory (Lexington, MA) and the
procedures were described previously (Trevisi et al., 2012; Batistel et al., 2016; Jacometo
et al., 2016).
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Rumen Fluid Collection and Analyses
Rumen fluid (~50 mL) was sampled on -59, -29, 5, and 30 d relative to parturition
from a subset of multiparous cows (n = 8 cows/treatment) via esophageal tubing. After
discarding the first 200 mL of fluid to minimize saliva contamination, approximately 50
mL of rumen fluid was collected. After collection, the rumen pH was immediately
measured using a pH meter (Waterproof pH Test 30, Oakton Instruments, Vernon Hills,
IL). Two aliquots of 10 mL were saved in a bottle containing either 200 µL of 50%
sulfuric acid or 2 mL of 25% metaphosphoric acid and stored at -20°C until analysis of
ammonia (NH3) and VFA respectively. Furthermore, 2 mL of rumen fluid sample was
immediately frozen in liquid nitrogen followed by storage at -80°C until DNA isolation
followed by relative abundance of bacteria species quantification via qPCR method.
Ammonia and VFA
Rumen fluid samples preserved with sulfuric acid and 25% meta-phosphoric acid
were thawed and transferred into a 2mL microcentrifuge tube and centrifuged at 30,000 ×
g for 20 min at 4°C (Model 5403, Eppendorf, Hamburg, Germany). The supernatant of
rumen fluid sample with sulfuric acid was used to analyze Ammonia-N concentration
using the assay described by Chaney and Marbach (1962). VFA concentrations were
measured in samples contained 25% metaphosphoric acid using an automated gas
chromatograph (Model 689, Hewlett-Packard, Palo Alto, CA) equipped with a 0.25 mm
i.d ×15 m capillary column (Nukol 24106-U, Sulpeco, Inc., Bellefonte, PA) and the
internal standard used was 2-ethylbutyrate.
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Ruminal Bacteria DNA Isolation and qPCR Amplification of 16S rDNA Genes
Ruminal bacteria DNA was isolated using the QIAmp Fast DNA Stool Mini Kit
(Qiagen, Hilden, Germany) with modifications to the protocol described by Henderson et
al. (2013). Briefly, 1mL of rumen fluid was centrifuged at 12,000 × g for 5 min and the
supernatant was discarded. Pellet was resuspended in 1 mL of buffer EX, vortex,
incubated in a heat block at 95°C for 5 min and centrifuged at 20,000 × g for 1 min.
Then, 600 L of supernatant was transferred to a new microcentrifuge tube contained 25
L of Qiagen Proteinase K, followed by addition of 600 L of Buffer AL. The mixture
was vortexed for 15 s and incubated at 70 C for 10 min. After incubation, 600 L of
96% molecular ethanol was added and vortexed. The mixture was transferred into a
QIAamp mini spin column, and the subsequent steps were performed according to
manufacturer’s procedures (Qiagen, Hilden, Germany). The DNA quantity and purity
were measured using a NanoDrop spectrophotometer (ND 1000, NanoDrop Technologies
Inc., Wilmington, DE) and the extracted DNA was standardized to 8 ng/µL for qPCR.
The primer sets used in this study have been previously reported and validated
(Table 2.2). The qPCR analysis was performed using 10 L of qPCR mixture containing
4 L of sample DNA, 5 L of 1 x SYBR Green master mix (Applied Biosystems,
Waltham, MA), 0.4 µL of 10 µM each for forward and reverse primers, and 0.2 µL of
DNase-RNase-free water in a MicroAmp Optical 384-well reaction plate (Applied
Biosystems). Each sample was run in triplicate and the qPCR reactions were performed
in a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems) using the same
conditions described by Grazziotin et al. (2020). A geometrical mean of two universal
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bacteria primers was used to calculate the relative abundance of bacterial species
(Abdelmegeid et al., 2018).
Statistical Analysis
Data were analyzed as repeated measures with the MIXED procedure of SAS
according to the following model:
𝑌𝑖𝑗𝑘𝑙𝑚 = 𝜇 + 𝐷𝑖 + 𝑃𝑗 + 𝐷𝑃𝑖𝑗 + 𝐵𝑘 + 𝐶𝑖𝑗𝑘𝑙 + 𝑇𝑚 + 𝐷𝑇𝑖𝑚 + 𝐷𝑃𝑇𝑖𝑗𝑚 + 𝑒𝑖𝑗𝑘𝑙𝑚
Where 𝑌𝑖𝑗𝑘𝑙𝑚 is the dependent, continuous variable; 𝜇 is the overall mean; 𝐷𝑖 is the
fixed effect of the ith diet (i = 1 and 2); 𝑃𝑗 is the fixed effect of the jth parity (j = 1, 2, 3);
𝐵𝑘 is the random effect of the kth block (k = 1, …20); 𝐶𝑖𝑗𝑘𝑙 is the random effect of lth cow
nested within the ith treatment, the jth parity, and the kth block (l = 1,…, 𝑛𝑖𝑗𝑘 ); 𝑇𝑚 is the
fixed effect of the mth time (d or wk) of the experiment (m = 1,… n); 𝐷𝑇𝑖𝑚 is the fixed
effect of the ith treatment by the mth time of the experiment interaction; 𝐷𝑃𝑇𝑖𝑗𝑚 is the
fixed effect of the ith treatment by the jth parity by the mth time of the experiment
interaction; and 𝑒𝑖𝑗𝑘𝑙𝑚 is the residual error. Parity effect was removed from the model any
time it was nonsignificant (P > 0.05). Blood biomarkers and rumen fluid data, including
pH, VFA, NH3, and relative abundance of microbial species were analyzed at various time
points that were not equally spaced; therefore, an exponential correlation covariance
structure SP (POW) was used for repeated measures. Blood biomarkers and relative
abundance of microbial species were log-scale transformed if needed to comply with
normal distribution of residuals. Blood biomarkers and rumen fluid data on -30 and -59 d,
respectively, were used as a covariate. The covariate of previous 305-d milk yield was
maintained in the model for all variables for which it was significant (P < 0.05). Statistical
significance was declared at P ≤ 0.05 and tendencies at P < 0.15.
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RESULTS
Peripartal DMI, BW, and BCS
Main effects and interactions for prepartal and postpartal BW, BCS, DMI, DMI as
percent BW, and EB are presented in Table 2.3. Neither the prepartal nor postpartal BW,
BCS, and DMI, DMI as %BW, and EB were affected (P ≥ 0.23) by dietary treatments.
Milk Production and Composition
Main effects and interactions for postpartal production variables and milk
efficiency in terms of Milk/DMI and ECM/DMI are presented in Table 2.4 and Figure
2.1. The SCC was lower (P < 0.01) in YC fed cows than CON. A trend for a diet effect
was observed in milk yield (P = 0.13) and ECM (P = 0.07), where YC cows produced 2.5
kg/d and 3.2 kg/d more than CON, respectively. Also, similar to milk yield, a trend (P =
0.11) was observed for a greater milk fat yield in YC cows when compared to CON. Milk
efficiency in terms of milk/DMI was not affected (P = 0.52) by dietary treatments, and
milk efficiency in terms of ECM/DMI even though it was ca. 0.10 greater in YC cows
than CON, this effect did not reach statistical significance (P = 0.18)
Rumen Fermentation
Main effects and interactions for rumen fermentation characteristics are presented
in Table 2.5. There was a D × T interaction observed in VFA concentrations of
isovalerate (P = 0.05) and valerate (P = 0.04) (Figure 2.2). The D × T in valerate was
mainly associated with greater (P = 0.01) concentration in YC cows than CON at 5 DIM.
In contrast to valerate, the D × T in isovalerate was reflected in lower (P < 0.01)
concentrations in YC cows than CON at -29 DIM. The latter was reflected in lower (P =
0.02) isovalerate in YC cows in comparison to CON.
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Abundance of Ruminal Bacteria
Main effects and interactions for the relative abundance of microbial species in
rumen fluid are presented in Table 2.6. There was a D × T (P ≤ 0.05) on the relative
abundance of Prevotella albensis, Prevotella bryantii, Prevotella ruminicola, and
Succinivibrio dextrinosolvens (Figure 2.3). Similarly, a trend for a D × T was observed in
Selenomonas ruminantium (P = 0.11) and Succinimonas amylolytica (P = 0.12) (Figure
2.3). The D × T observed in P. albensis was associated with a greater (P = 0.03)
abundance of this bacterium in YC cows than CON at 30 DIM. The D × T in P.
ruminicola resulted in lower (P = 0.01) abundance of this bacterium in YC cows in
comparison to CON at 5 DIM. Similar to P. ruminicola, S. ruminantium tended (P =
0.12) to be lower in YC cows in comparison to CON at 5 DIM. The D × T in S.
dextrinosolvens (P = 0.02) and P. bryantii (P = 0.04) resulted in a similar pattern, where
lower in YC cows than CON at -29 DIM. Contrary to S. dextrinosolvens and P. bryantii,
S. amylolytica had a greater (P = 0.01) abundance in YC cows than CON at -29 DIM.
There was a greater relative abundance of Megaspheara elsdenii (P = 0.05) and S.
amylolytica (P = 0.03) in YC cows than CON (Table 2.6). In contrast to M. elsdenii and
S. amylolytica, P. brevis abundance was lower (P < 0.01) in YC cows in comparison to
CON. In addition, there was a trend for greater abundance of Anaerovibrio lipolytica (P
= 0.12) and Fibrobacter succinogenes (P = 0.09) in YC cows than CON (Figure 2.4).
Blood Biomarkers
Main effects and interactions for blood biomarkers of muscle body mass,
metabolism, and oxidative stress are presented in Table 2.7. There was a D × T (P = 0.02)
in NEFA and a trend (P = 0.13) in BHB (Figure 2.5). The D × T in NEFA resulted in
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lower NEFA in YC cows than CON at -15 (P = 0.05), 14 (P = 0.05), and 30 d (P = 0.02)
relative to parturition, while a tendency (P = 0.12) for greater NEFA was observed in YC
cows than CON at 7 DIM. The latter effects can be attributed to a trend for overall lower
NEFA (P = 0.10) in YC cows than CON. Similar to NEFA, the D × T in BHB was
associated with a tendency for a greater (P = 0.10) BHB in YC cows than CON at 7 DIM,
followed by a trend for lower (P = 0.11) BHB in YC cows than CON at 30 DIM.

DISCUSSION
Effects on DMI, BW, and BCS
Peripartal dairy cows commonly experience a decline in DMI around parturition.
(Drackley, 1999). This decline in DMI results in low energy intake, which has been
associated with BCS and hormonal changes around parturition (Ingvartsen and Andersen,
2000). As a result of this decrease in energy intake, dairy cows enter a negative energy
balance (NEB) that is exacerbated by the substantial increase in energy demands to
sustain milk production after calving. Dairy cows respond to NEB by mobilizing lipid
from adipose tissue in the form of NEFA, to cope with energy demands in early lactation
(Contreras and Sordillo, 2011). Because of these reasons, it is typical to observe a
decrease in BCS and BW in dairy cows during early lactation.
Yeast culture has supplemented to dairy cows with the aim of improving
performance and health (Poppy et al., 2012). Yeast culture supplementation has been
reported to affect DMI in transition dairy cows(Olagaray et al., 2019; Shi et al., 2019;
Stefenoni et al., 2020). For instance, Shi et al. (2019) reported a trend for an increase in
DMI during the first week after calving in dairy cows supplemented with 19 g/d of S.
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cerevisiae fermentation product. Similarly, Dann et al. (2000) observed improvements in
DMI during the first 42 DIM in peripartal Jersey dairy cows fed 60g/d of a yeast culture
product. In the current study, yeast culture supplementation did not statistically affect
peripartal DMI, and by extension, no effect on BW or BCS was observed around
parturition.
Milk Production and Milk Components
There is a lack of consistency on the milk yield response to yeast supplementation
in dairy cows. This is predicated on the multiple forms (e.g., active and dead), packing,
and metabolites that can be incorporated in commercial yeast supplements. For instance,
feeding yeast culture products has been observed to increase milk yield between 3.3 and
5.2 kg/d in transition and mid-lactation dairy cows (Zaworski et al., 2014; Dias et al.,
2018). Robinson and Erasmus (2009) reviewed several yeast culture studies in dairy
cows and reported that overall yeast supplementation has a positive effect on milk yield
(~ 0.9 kg/d). In contrast, some studies reported a lack of effect on milk production in
transition dairy cows (Yuan et al., 2015a; Olagaray et al., 2019; Stefenoni et al., 2020). A
positive effect on milk production was observed in YC cows with an increase of 2.5 kg/d,
which was within the range of milk yield improvement observed in previous studies
feeding yeast supplements.
Yeast culture supplementation has been observed to effect milk fat yield in early
and mid-lactation dairy cows (Dias et al., 2018; Perdomo et al., 2020). Olagaray et al.
(2019) observed 0.13kg/d increase in milk fat yield at 4 and 5 wk postpartum, feeding 19
g/d of yeast culture during the peripartal period, which was similar to the 0.16 kg/d
increase in milk fat yield observed in YC cows in comparison to CON. Diets containing
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relatively high levels of unsaturated fats and starch have been associated with milk fat
depression in dairy cows due to increased flow of trans FAs from ruminal fermentation
(Bradford and Allen, 2004). In this context, Longuski et al. (2009) reported that lactating
dairy cows supplemented with a yeast culture had a higher degree of resistance to milk
fat depression during a short-term dietary challenge with fermentable starch. This can be
partially ascribed to yeast maintaining a favorable rumen fermentation for cellulolytic
bacteria which is the primary source of ruminal acetate. Therefore, yeast supplementation
may indirectly promote a stable supply of acetate for milk fat synthesis by maintaining a
favorable population of cellulolytic bacteria (Ghazanfar et al., 2017).
The benefits of yeast culture supplementation on milk performance paramenters,
in the present study were reflected in ECM and milk efficiency in terms of ECM/DMI.
These results agree with those of Perdomo et al. (2020) and Dias et al. (2018), where
yeast products caused an increase in ECM. Perdomo et al. (2020) observed that under
heat stress conditions, lactating cows fed with 1g of live yeast had an increase in ECM
and feed efficiency measured as ECM/DMI, and such effects were attributed to
improvements in crude protein and NDF digestibility. According to Dias et al. (2018),
supplementation of yeast culture from S. cerevisiae could increase ECM in lactating cows
fed diets varying in starch content. In contrast, others did not observed positive effects in
ECM in transition dairy cows supplemented with yeast derived from S. cerevisiae (Yuan
et al., 2015a; Stefenoni et al., 2020). The fermentable products present in the YC product
may have improved nutrient utilization by ruminal bacteria and consequently allowed a
higher milk efficiency in YC fed cows.
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Improvements in udder health, in terms of SCC, have been observed when
feeding yeast culture products to dairy cows. For instance, Nocek et al. (2011) tested a
yeast culture product alone or in combination with an enzymatically hydrolyzed yeast fed
to dairy cows from calving to 14 wk postpartum, and this combination resulted in lower
SCC through the first 14 weeks of lactation.(Zaworski et al., 2014). reported positive
effects on SCC during the first 4 wk postpartum, when supplementing different dosages
of S. cerevisiae fermentation product. Those effects were attributed to a potential
activation of the animal’s immune system at the gut level by antigenic exposure in the
form of β-glucans and mannan-oligosaccharides presented in some yeast products.
Besides a systemic activation of the immune system as described by Nocek et al. (2011),
the action of β-glucans has been tested at the local level during a mastitis induction
(Waller et al., 2003). Waller et al. (2003) evaluated the effects of an intramammary
infusion of β-1,3-glucan in dairy cows under a chronic subclinical mastitis model induced
by Staphylococcus aureus. They did not observe any benefical effects of β-1,3-glucan on
reducing subclinical mastitis. However a tendency to increase milk lymphocytes after β1,3-glucan infusion was observed, suggesting that, to some extent, β-1,3-glucan may
stimulate a better local inflammatory response by increasing immune cell recruitment.
Rumen Fermentation Parameters
Dietary carbohydrates are fermented by ruminal bacteria, fungi, and protozoa into
end products, including VFA (e.g., acetate, propionate, and butyrate) that make up for
nearly 50% of the energy requirements for ruminants (Puniya et al., 2015). Desnoyers et
al. (2009) reported in a meta-analysis that yeast supplementation increased total VFA
concentration in domesticated ruminant species. Zhu et al. (2017) reported a positive
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effect on total VFA when dairy cows were supplemented with S. cerevisiae fermentation,
which was associated with a stimulatory effect on rumen microbial population, including
cellulolytic bacteria. In the current study, total VFA production was not affected by yeast
culture supplementation.
The normal transition of dairy cows from late pregnancy into lactation is
predicted on the cow’s ability to adapt to a postpartal lactation diet, which leads to
increase ruminal butyrate and valerate, while other VFAs such as isobutyrate and
isovalerate remained unchanged (Minuti et al., 2015). The primary ruminal VFAs (i.e.,
acetate, propionate, and butyrate) seem to be less responsive to yeast supplementation in
transition dairy cows (Robinson and Garrett, 1999; Kumprechtova et al., 2019). Like in
transition dairy cows, yeast culture and live yeast culture supplementation in midlactation dairy cows did not elicit an effect on acetate, propionate, and butyrate (Dias et
al., 2018, Meller et al., 2019). In agreement with those data, our results showed
supplementing YC during the transition period did not influence VFA concentrations.
Ruminal isoacids comprised of isobutyrate, 2-methylbutyrate, isovalerate, and
valerate have been found to increase in response to yeast culture supplementation
(Andries et al., 1987). For instance, in an experiment testing incremental levels of
concentrate plus yeast culture supplementation (1g/kg of TMR as fed), yeast culture was
shown to increase the concentration of isobutyrate and isovalerate regardless of
concentrate level in the diet in cannulated Holstein dairy heifers (Lascano and Heinrichs,
2009). Lactating dairy cows fed with a high dose of inactivated yeast increased the molar
proportion of valerate, compared with control cows (Jiang et al., 2017a), which is
consistent with the increase in valerate in YC cows at 5 DIM in the current study. An
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alternative explanation for the increase in valerate could be associated with the greater M.
elsdenii in YC cows, which was more evident postpartum (Figure 2.4 C). The latter is
based on the fact that M. elsdenii can ferment L-lactate into propionate and subsequently
valerate (Weimer and Moen, 2013). In addition, live yeast supplementation increased the
concentration of isovalerate in early lactation dairy cows under heat stress conditions
(Garcia Diaz et al., 2018; Perdomo et al., 2020). Similar findings for isovalerate were
observed in the current study, where this isoacid increased in YC cows in early lactation.
However, others have observed a lack of response of valerate and isovalerate
concentration to supplementation of active dry S. cerevisiae in cannulated lactating dairy
cows (AlZahal et al., 2014). Interestingly, Harrison et al. (1988) and coworkers observed
a decrease in molar proportion of isovalerate while valerate increased in lactating cows
fed a yeast culture supplement, and this effect was attributed to lower ruminal pH. The
positive effects of yeast in ruminal valerate concentrations can be associated with
changes in metabolic activities of ruminal bacteria, including amylolytic, cellulolytic, and
lactate-utilizer populations. For instance, ruminal degradation of proteins by amylolytic
bacteria commonly leads to production of isoacids (Dawson et al., 1990), while the
fermentation pathway of lactate by ruminal bacteria may lead to the production of
valerate (Weimer and Moen, 2013). These isoacids are required for most cellulolytic
bacteria to degrade fiber, underscoring the essential role of isoacids for fiber digestibility
(Liu et al., 2009).
Yeast Culture and Ruminal Bacteria Species
In transition dairy cows, rumen microbial populations are expected to change
around parturition, which can be attributed to a natural adaptation of rumen microbes to a

47

lactating cow diet after calving. Minuti et al. (2015) reported diet changes after calving
could result in a decrease in fiber digesting bacteria. According to Lima et al. (2015), the
main differences between prepartal and postpartal bacterial populations encompass
changes in cellulolytic and amylolytic bacteria followed by variations in other uncultured
bacteria species for which a ruminal function remains unknown.
The rumen environment is malleable, to some extent, and positive modifications
can affect bacteria population and, by extension, its fermentation products, leading to
improved performance and nutrient utilization in ruminants (Ghazanfar et al., 2017).
Different mechanisms have been proposed to explain the action of yeast in the rumen.
According to Jouany (2006), live yeast can interact with ruminal bacteria in a “microconsortium structure”, by promoting a localized anaerobiosis in freshly ingested particles
(e.g., forages and starch) that may contain oxygen, thus benefiting bacterial digestion.
Yeast uses oxygen to metabolize sugars and oligosaccharides, which results in endproducts (e.g., ethanol, glycerol, peptides, and amino acids) utilized by bacteria
associated with yeast (Jouany, 2006). In addition, yeast culture products provide
mannooligosaccharides and glucans present in the yeast cell wall that can be highly
degradable in the rumen, as well as fermentable metabolites, minerals, and enzymes that
can change the profile and physiology of ruminal bacteria, stimulating the growth of
cellulolytic, amylolytic, and proteolytic bacteria (Chaucheyras-Durand et al., 2008;
Ghazanfar et al., 2017; Jiao et al., 2019).
The impact of yeast culture products on ruminal bacteria sbudance have been
evaluated in lactating dairy cows (AlZahal et al., 2014; Zhu et al., 2017; Jiao et al., 2019)
and transition dairy cows (Bach et al., 2019). There were positive effects in bacterial

48

populations in YC cows in the current study, mainly by increasing lactate and fiber
digesting bacteria. Similar to the current study, early lactating dairy cows supplemented
with live yeast presented a greater abundance of lactate-utilizing bacteria (Megasphaera)
and fiber digesting bacteria (Fibrobacter) (Pinloche et al., 2013).
Minuti et al. (2015) observed a decrease in postpartal F. succinogenes abundance
in transition dairy cows, primarily driven by high grain content in the lactation diet.
Strains of S. cerevisiae have been reported to increase the abundance and activity of fiber
digesting bacteria in rumen, such as Fibrobacter spp. (Jiang et al., 2017b). A trend (P =
0.09) for a greater F. succinogenes abundance in YC cows compared to CON was
observed, and such effect was more evident at 30DIM (Figure 2.4B). A more pronounced
effect for greater F. succinogenes was observed by AlZahal et al. (2014) in cannulated
lactating dairy cows fed with active dry S. cerevisiae. A similar response was reported by
Zhu et al. (2017), where F. succinogenes increased linearly in lactating dairy cows
receiving incremental amounts (0, 60, 120, and 160 g/d) of S. cerevisiae fermentable
products. In contrast, other studies in vitro and in vivo did not observe a yeast effect in F.
succinogenes abundance (Mullins et al., 2013; Jiao et al., 2019). Yeast culture used in the
current experiment contained live yeast, which could have promoted localized
anaerobiosis, and, in turn, this could partially explain the trend for a greater abundance of
F. succinogenes.
Lactate-associated bacteria such as Megasphaera elsdenii and Anaerovibrio
lipolytica can utilize lactate as an energy source and, consequently, slower growth rates
of these bacteria are observed in low carbohydrate diets (Russell, 2002; Puniya et al.,
2015). Increased abundance of M. elsdenii and A. lipolytica has been observed in
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transition dairy cows after calving, which was attributed to greater DMI and starch
digestibility (Minuti et al., 2015). Similarly, live yeast supplementation has been reported
to increase ruminal abundance of M. elsdenii (Ogunade et al., 2019) and A. lipolytica
(AlZahal et al., 2014).In the present study, lactate was not evaluated, but M. elsdenii and
A. lipolytica increased after calving, which is consistent with greater starch content in
lactation diets. Additionally, the increase in the abundance of these bacteria in YC cows
was more pronounced at 30 DIM (Figure 2.4A and 2.4C), suggesting that these bacteria
were affected by yeast supplementation beyond the expect increased due to greater starch
content in the lactation diet.
Abdelmegeid et al. (2018) observed a higher abundance of S. dextrinosolvens
during prepartum than postpartum, and S. amylolytica tended to follow the same pattern.
In contrast, we observed no change over time in both bacteria, regardless of treatment
(Figure 2.3E and 2.3F). These data are conflicting with these bacterias’s known starchdegrading function (Russell, 2002), which implies that such bacteria abundance should
increase postpartum. In contrast to these findings, AlZahal et al. (2014) did not report a
change in population of either S. amylolytica and S. dextrinosolvens when supplementing
lactating dairy cows with active dry Saccharomyces cerevisiae. There was a prepartal
increase of S. amylolytica with a contrasting decrease of S. dextrinosolvens in YC cows
compared to CON. These effects on S. amylolytica and S. dextrinosolvens took place
within 24 hours after initial supplementation with YC (-30 DIM), which render these
effects as short-term and potentially transient as the rumen adapted to the YC
supplementation.
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Prevotella species can use a variety of substrates, such as starch, hemicellulose,
pectin, β-glucans, and proteins, to produce acetate, propionate, succinate, and formate
(Russell, 2002). The presence of Prevotella spp. in rumen across a variety of diets
indicate the substantial metabolic diversity of this genus (Zeineldin et al., 2018).
According to Stevenson and Weimer (2007), bacteria population of the genus Prevotella
spp. are the most dominant bacteria in rumen, but only a small percentage is composed of
P. bryantii, P. brevis, and P. ruminicola in lactating dairy cows fed with a normal TMR
diet. This was later confirmed by Lima et al. (2015), showing that Prevotella is the most
abundant bacterium in transition cows.
In the current study, different responses due to YC supplementation were
observed for P. albensis, P. bryantii, P. brevis, and P. ruminicola, confirming the
metabolic diversity of this genus in the rumen. Supplementation of active dry S.
cerevisiae reduced the population of P. albensis, and no effects were observed in P.
bryantii and P. brevis in cannulated lactating dairy cows (AlZahal et al., 2014). Our
findings showed a greater abundance of P. albensis in YC cows at 30DIM (Figure 2.3 A),
suggesting that YC supplementation coupled with an eventual adaptation to the lactation
diet promoted an increase of this bacterium. P. bryantii was lower in cows supplemented
with YC at -29 DIM, which seems to be similar to S. amylolytica and S. dextrinosolvens,
where such effect might be transient as a 24 h response to YC supplementation. Overall,
P. bryantii increased postpartum regardless of dietary treatments (Figure 2.3 B), which
was a similar pattern observed by Minuti et al. (2015). Subacute ruminal acidosis induced
via grain or alfalfa pellets cause a differential response among the Prevotella genus,
specifically, P. ruminicola and P. albensis, which further underscore the metabolic
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diversity of this genus (Khafipour et al., 2009). Our results suggest that Prevotella spp.
evaluated in this study behave differently due to the YC supplementation, which is in line
with previous differential response across Prevotella spp. An alternative explanation for
the differential abundance among Prevotella spp. can be related to their ability to use
signaling molecules such as N-Acyl homoserine lactones to communicate between
bacteria in an orchestrated effect to coordinate bacterial population density, also known
as quorum sensing (Won et al., 2020). Interactions through quorum sensing have been
evaluated between yeast and bacteria (Proust et al., 2020). However, the specific
mechanisms and interactions between YC products and ruminal bacteria such as
Prevotella spp. remains unclear.
Taken together, we observed that yeast culture supplementation promoted changes
in rumen bacteria species across cellulolytic, amylolytic, and lactate-utilizer populations.
These effects seem to have promoted beneficial rumen fermentation, at least in terms of
valerate, which might have promoted better fiber digestion. The researchers speculate that
the presence of lactate-utilizer bacteria can be helpful during the periods where the diet
changes abruptly, such as the transition period. The abrupt change from a high-fiber diet
prepartum to a lactation diet postpartum containing large amounts of fermentable
carbohydrates can commonly lead to decreased pH, altering ruminal bacteria population
and predisposing transition dairy cows to metabolic disorders.
Blood Biomarkers
During the transition period, dairy cows experience a reduction in energy balance,
and lipid mobilization becomes a physiological adaptation mechanism to offset or
compensate the NEB (Contreras and Sordillo, 2011). Lipid mobilization is associated
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with hormonal changes around parturition, and it is commonly characterized by an
excessive lipolysis rate over lipogenesis (Bradford et al., 2015). The main product of
triglyceride hydrolysis in adipose tissue during lipid mobilization is NEFA, and it and
serves as an alternative energy substrate for most tissues (Contreras and Sordillo, 2011).
Blood NEFA reflects the level of NEB in transition dairy cows, and greater NEFA is
commonly associated with fatty liver syndrome and increased production of ketone
bodies. (Ingvartsen and Andersen, 2000; Ingvartsen, 2006). During NEB, the liver
exceeds its capacity for oxidizing NEFA, which leads to partial oxidation of NEFA and,
consequently, increasing BHB synthesis (Ingvartsen and Andersen, 2000). The latter is
released into the bloodstream and serves as fuels for other tissues (Ingvartsen and
Andersen, 2000). Minuti et al. (2015) detected lower prepartal NEFA and BHB, followed
by a rapid increase after parturition, with the highest concentrations at 10 and 20 DIM.
Inconsistent responses on blood NEFA and BHB have reported when feeding
yeast culture products to transition dairy cows (Al Ibrahim et al., 2010; Yuan et al.,
2015a; Faccio-Demarco et al., 2019). For instance, Al Ibrahim et al. (2010) supplemented
transition dairy cows with live yeast, and no effects were observed in NEFA and BHB.
Similarly, Faccio-Demarco et al. (2019) supplemented 28 g/d of yeast culture plus
enzymatically hydrolyzed yeast of S. cerevisiae to transition dairy cows and they did not
observe differences in NEFA and BHB levels. Transition dairy cows fed with S.
cerevisiae in combination with two Enterococcus strains from -21 to 70 d relative to
parturition had lower postpartal NEFA and BHB concentrations after 8 and 22 DIM,
respectively (Nocek et al., 2003). Yuan et al. (2015a) reported that a combination of live
yeast culture plus enzymatically hydrolyzed yeast at the rate of 0, 30, 60, and 90 g/d from
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-21 to 42 d relative to parturition cause an overall postpartal increase in BHB in yeast fed
cows regardless of the level of supplementation.
A postpartal increase in NEFA and BHB in YC cows was observed with the
highest concentrations at 7 DIM. These responses were similar to those observed in
transition dairy cows diagnosed with subclinical ketosis (Mezzetti et al., 2019) with
maximal NEFA and BHB values at 7 DIM. However, the levels of NEFA and BHB (0.77
and 0.72 mmol/L, respectively) in YC cows were much lower than those observed by
Mezzetti et al. (2019). The latter suggests that the level of lipid mobilization in YC cows
was not conducive to subclinical ketosis development. In addition, we observed that
NEFA and BHB in YC cows declined more sharply after 7 DIM than CON cows. The
reasons underlying this observation are unclear but suggest a potential effect of yeast
product on lipid metabolism in transition dairy cows.

CONCLUSIONS
Yeast culture products have been fed to peripartal dairy cows for many years to
improve milk yield and milk efficiency. The findings of this study revealed that YC
promoted positive responses on performance, such as milk yield, SCC, and ECM. In the
rumen, YC contributed to increased valerate soon after calving. The latter was
accompanied by increments in rumen microbiota populations such as cellulolytic and
lactic acid-utilizing. The supply of the yeast culture product and its fermentation
metabolistes in rumen, could be a source of substrates for ruminal bacteria that can
promote improvements in fermentable characteristics and optimize the relative
abundance of microbial species. In addition, the yeast culture product may influenced
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lipid metabolism in transition dairy cows, but this mechanism remains to be elucidated.
The results describe an overall beneficial effect of supplementing YC during the
transition period through early lactation, at least in terms of rumen environment and
performance.
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Table 2.1 - Ingredient composition of diets during the close-up (-30d to expected calving)
and early lactation periods.
Diet
Component
Ingredient, % DM1
Corn silage
Alfalfa silage
Alfalfa hay
Grass Hay
Cotton seed
Wheat straw
Soy best
Corn grain ground fine
Soybean meal
Distillers grains dry
Animate3
Wheat midds
Calcium carbonate
Calcium phosphate Di
Sodium bicarbonate
Energy booster 1002
Salt white
Magnesium oxide
Urea 281% CP
JPW Dairy Vitamin Premix4
JPW Dairy TM Premix5
Dairy VTM
Mepron
Vitamin E, 20000 UI/lb
Biotin 1%
Rumensin 90
Chemical analysis
DM, %
NEL, Mcal/ kg DM
CP, % DM
NDF, % DM
ADF, % DM
DCAD, mEq/100 g
1Ingredients

Close-up

Lactation

37.5
------23.9
---12.6
10.5
3.1
4.67
---3.72
---2.61
0.52
------0.19
0.21
---0.13
0.10
0.14
---0.10
---0.01

36.31
8.71
15.97
---8.25
------16.07
3.65
3.66
---3.65
1.00
---0.91
0.91
0.34
0.16
0.11
0.10
0.10
---0.04
0.04
0.01
0.01

49.81
1.54
12.31
46.39
28.78
-9.70

50.61
1.60
15.56
38.55
25.83
--

included in the ration formulated by using Spartan Dairy Ration Evaluator 3.0
Animate was used as the sole DCAD anion source.
3 Energy Booster 100 (MSC, Carpentersville, IL)
4Contained: 25.8 % Ca (DM basis) 1,545 IU/kg of Vitamin A, 387 IU/kg of Vitamin D, and 4,826 IU/kg of Vitamin E
(JPW Nutrition, Sioux Falls, SD).
5Contained: 11.7 % Ca (DM basis), 1.96 % S, 10,527 mg/kg of Fe, 63,158 mg/kg of Zn, 12,632 mg/kg of Cu, 63,158
mg/kg of Mn, 325 mg/kg of Se, 632 mg/kg of Co, and 1,053 mg/kg of I (JPW Nutrition, Sioux Falls, SD).
2
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Table 2.2 - Species-specific primers used in real-time qPCR assay for the quantification
of selected rumen bacteria population.
Target bacterial species
Anaerovibrio lipolytica
Butyrivibrio fibrisolvens
Butyvibrio proteoclasticus
Eubacterium ruminantium
Fibrobacter succinogenes
Megaspheara elsdenii
Prevotella albensis
Prevotella brevis
Prevotella bryantii
Prevotella ruminicola
Rumicoccus albus
Rumicoccus flavefaciens
Ruminobacter amylophilus
Selenomonas ruminantium
Succinimonas amylolytica
Succinivibrio dextrinosolvens
Streptococcus bovis
Treponema bryantii
Bacteria general 1
Bacteria general 2
aF:
bR:

forward primer
reverse primer

Fa
Rb
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

Primer sequence (5’- 3’)
GAAATGGATTCTAGTGGCAAACG
ACATCGGTCATGCGACCAA
ACACACCGCCCGTACCA
TCCTTACGGTTGGGTCACAGA
GGGCTTGCTTTGGAAACTGTT
CCCACCGATGTTCCTCCTAA
CTCCCGAGACTGAGGAAGCTTG
GTCCATCTCACACCACCGGA
GCGGGTAGCAAACAGGATTAGA
CCCCCGGACACCCAGTAT
AGATGGGGACAACAGCTGGA
CGAAAGCTCCGAAGAGCCT
GCGCCACTGACGCTGAAG
CCCCAAATCCAAAAGGACTCAG
GGTTTCCTTGAGTGTATTCGACGTC
CTTTCGCTTGGCCGCTG
AGCGCAGGCCGTTTGG
GCTTCCTGTGCACTCAAGTCTGAC
GAAAGTCGGATTAATGCTCTATGTTG
CATCCTATAGCGGTAAACCTTTGG
ACGTCRTCCMCACCTTCCTC
CCTCCTTGCGGTTAGAACA
CGAACGGAGATAATTTGAGTTTACTTAGG
CGGTCTCTGTATGTTATGAGGTATTACC
CTGGGGAGCTGCCTGAATG
GCATCTGAATGCGACTGGTTG
CAATAAGCATTCCGCCTGGG
TTCACTCAATGTCAAGCCCTGG
CGTTGGGCGGTCATTTGAAAC
CCTGAGCGTCAGTTACTATCCAGA
TAGGAGCTTGTGCGATAGTATGG
CTCACTATGTCAAGGTCAGGTAAGG
TTCCTAGAGATAGGAAGTTTCTTCGG
ATGATGGCAACTAACAATAGGGGT
AGTCGAGCGGTAAGATTG
CAAAGCGTTTCTCTCACT
GGATTAGATACCCTGGTAGT
CACGACACGAGCTGACG
GTGSTGCAYGGYTGTCGTCA
ACGTCRTCCMCACCTTCCTC

Reference
(Abdelmegeid et al., 2018)
(Klieve et al., 2003)
(Abdelmegeid et al., 2018)
(Abdelmegeid et al., 2018)
(Abdelmegeid et al., 2018)
(Abdelmegeid et al., 2018)
(Khafipour et al., 2009)
(Stevenson and Weimer,
2007)
(Abdelmegeid et al., 2018)
(Stevenson and Weimer,
2007)
(Koike and Kobayashi, 2001)
(Denman and McSweeney,
2006)
(Stevenson and Weimer,
2007)
(Abdelmegeid et al., 2018)
(Abdelmegeid et al., 2018)
(Abdelmegeid et al., 2018)
(Abdelmegeid et al., 2018)
(Tajima et al., 2001)
(Abdelmegeid et al., 2018)
(Abdelmegeid et al., 2018)

57

Table 2.3 - Effects of supplementing cows with a control diet (CON) or control diet plus
yeast culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal
Health, Teaneck, NJ) in dairy cows during the peripartal period until 50DIM on BW,
BCS, DMI, and energy balance.

Parameter
Prepartum1
BW, kg
BCS
DMI, kg/day
DMI, % BW
EB, Mcal/day
Postpartum2
BW, kg
BCS
DMI, kg/day
DMI, % BW
EB, Mcal/day
1Prepartum

Treatment
CON
YC

SEM

Diet

P-value
Parity
Time
4

D x T5

773
3.12
12.2
1.5
4.01

785
3.19
12.7
1.6
3.50

16.4
0.08
0.61
0.07
1.02

0.61
0.56
0.59
0.95
0.65

<0.01
---0.02

0.36
0.12
<0.01
0.02
0.02

0.36
0.81
0.21
0.24
0.36

688
2.79
19.9
2.8
-4.30

688
2.81
20.5
2.9
-5.93

13.75
0.04
0.47
0.07
1.26

0.99
0.77
0.40
0.54
0.23

<0.01
-<0.01
-0.27

<0.01
<0.01
<0.01
<0.01
0.17

0.92
0.28
0.87
0.97
0.98

parameters were analyzed from -30 d to calving.
parameters were analyzed from calving to 50 DIM.
3Largest standard error of the mean.
4Interaction of treatment and days in milk.
2Postpartum

3
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Table 2.4 - Effects of supplementing cows with a control diet (CON) or control diet plus
yeast culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal
Health, Teaneck, NJ) in dairy cows during the peripartal period until 50DIM on milk
composition.
Parameter
Milk yield, kg/d
Milk composition
Milk fat, %
Milk fat yield, kg/d
Milk protein, %
Milk protein yield, kg/d
Milk lactose, %
SCC3
MUN, mg/dL
ECM, kg/day
Milk/DMI
ECM/DMI
1Largest

Treatment
CON
YC
34.3
36.8
3.31
1.30
3.18
1.06
4.92
1.84
10.46
35.2
1.90
1.89

standard error of the mean
of treatment and days in milk
3Somatic cell counts were transformed to Log10
2Interaction

3.28
1.46
3.14
1.12
4.94
1.55
10.72
38.4
1.95
1.99

SEM
1.15

Diet
0.13

P-value
Parity Time
<0.01 <0.01

0.14
0.07
0.05
0.03
0.02
0.05
0.57
1.22
0.05
0.05

0.88
0.11
0.52
0.26
0.55
<0.01
0.74
0.07
0.52
0.18

-<0.01
-<0.01
-<0.01
-<0.01
---

1

<0.01
0.19
<0.01
<0.01
<0.01
0.58
0.02
<0.01
<0.01
0.03

D × T2
0.78
0.59
0.97
0.71
0.95
0.58
0.75
0.96
0.97
0.78
0.96
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Table 2.5 - Effects of supplementing cows with a control diet (CON) or control diet plus
yeast culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal
Health, Teaneck, NJ) in dairy cows during the peripartal period until 50DIM on VFA
percentages.
Parameter
pH
NH3, mg/dL
Total VFA, nM
VFA (mol/100 mol)
Acetate, %
Propionate, %
Butyrate, %
Isovalerate, %
Valerate, %
Acetate:Propionate
1Largest

Treatment
CON
YC
6.2
6.4
10.4
9.9
94.1
91.9
64.6
24.3
8.6
1.5
0.9
2.7

standard error of the mean.
of treatment and days in milk.

2Interaction

64.7
24.1
9.0
1.4
1.0
2.7

SEM1
0.08
0.78
4.82

Diet
0.22
0.68
0.74

Parity
-<0.01
--

P-value
Time
< 0.01
0.11
0.40

D × T2
0.90
0.52
0.37

0.84
0.77
0.26
0.04
0.04
0.09

0.93
0.85
0.26
0.02
0.24
0.94

--0.01
-<0.01
--

<0.01
<0.01
0.02
<0.01
<0.01
<0.01

0.88
0.77
0.79
0.05
0.04
0.92
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Table 2.6 - Relative abundance (%) of target bacterial species mixed ruminal fluid from
peripartal dairy cows supplemented with control diet (CON) or control diet plus yeast
culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health,
Teaneck, NJ).
Treatment
2

Species
Anaerovibrio lipolytica
Butyrivibrio fibrisolvens
Butyvibrio proteoclasticus
Eubacterium ruminantium
Fibrobacter succinogenes
Megaspheara elsdenii
Prevotella albensis
Prevotella brevis
Prevotella bryantii
Prevotella ruminicola
Rumicoccus albus
Rumicoccus flavefaciens
Ruminobacter amylophilus
Selenomonas ruminantium
Succinimonas amylolytica
Succinivibrio dextrinosolvens
Streptococcus bovis
Treponema bryantii
1Largest

CON
1.36 × 10-3
8.53 × 10-4
1.28 × 10-1
8.51 × 10-3
5.52 × 10-2
3.65 × 10-4
2.61 × 10-3
8.74 × 10-2
2.96 × 10-2
8.20 × 10-1
2.59 × 10-3
6.38 × 10-4
1.29 × 10-3
2.32 × 10-1
1.85 × 10-3
5.22 × 10-3
9.62 × 10-4
4.37 × 10-3

YC
1.83 × 10-3
9.92 × 10-4
1.28 × 10-1
9.04 × 10-3
7.27 × 10-2
5.53 × 10-4
4.58 × 10-3
7.12 × 10-2
2.30 × 10-2
7.43 × 10-1
2.59 × 10-3
6.51 × 10-4
2.63 × 10-3
2.39 × 10-1
4.63 × 10-3
6.78 × 10-3
9.54 × 10-4
5.62 × 10-3

1

SEM
0.19
0.15
0.15
0.22
0.15
0.22
0.65
0.04
0.58
0.11
0.23
0.38
0.82
0.10
0.39
0.53
0.27
0.33

Diet
0.12
0.32
0.98
0.78
0.09
0.05
0.40
<0.01
0.66
0.36
0.99
0.96
0.39
0.73
0.03
0.63
0.97
0.46

P-value
Time
D × T3
0.26
0.39
0.27
0.87
0.37
0.48
0.25
0.39
0.04
0.47
<0.01
0.49
<0.01
0.01
0.04
0.70
<0.01
0.05
0.99
0.02
0.19
0.98
0.08
0.26
0.42
0.45
0.04
0.11
0.13
0.12
0.66
0.05
0.02
0.42
0.18
0.76

standard error of the mean is shown.
were log-transformed before statistics. The standard errors of the means associated with log-transformed data are
in log scale.
3Interaction of treatment and days in milk.
2Data
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Table 2.7 - Effects of supplementing cows with a control diet (CON) or control diet plus
a yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro
Animal Health, Teaneck, NJ) in blood biomarkers related to muscle body mass,
metabolism and oxidative stress in dairy cows during the peripartal period until 50DIM.
Parameter
Muscle body mass
Creatinine, µmol/L
Urea, mmol/L
Metabolism
Glucose, mmol/L
NEFA, mmol/L2
BHB, mmol/L2
Oxidative stress
ROM, mg H2O2/100 mL
FRAP, µmol/L2
1Largest

Treatment
CON
YC

SEM

1

Diet

P-value
Time
D × T3

88.1
4.60

89.6
4.58

1.04
0.14

0.30
0.92

< 0.01
0.19

0.56
0.39

4.24
0.31
0.43

4.24
0.25
0.42

0.05
0.12
0.06

0.98
0.10
0.83

< 0.01
< 0.01
< 0.01

0.84
0.02
0.13

0.52
0.04

0.19
0.28

0.03
< 0.01

0.40
0.48

14.0
142.0

15.0
136.3

standard error of the mean is shown.
were log-transformed before statistics. The standard errors of the means associated with log-transformed data are
in log scale.
3Interaction of treatment and days in milk.
2Data
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2.2

Diet, P = 0.13
Time, P <0.01
Diet x Time, P = 0.78
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Figure 2.1 - Milk yield (A), SCC (B), ECM (C) and ECM/DMI (D) in cows
supplemented with a control diet (CON) or control diet plus yeast culture (YC; Cellerate
Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck, NJ) in dairy
cows during the transition period until 50DIM. Values are means and the standard errors
are represented by vertical bars.
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1.6

Valerate (%)

1.4

Diet, P = 0.24
Time, P < 0.01
Diet x Time, P = 0.04

A
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Figure 2.2 - Effects of control diet (CON) or control diet plus a yeast culture supplement
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck,
NJ) on ruminal valerate and isovalerate in dairy cows during the transition period until
50DIM. Values are means and the standard errors are represented by vertical bars.
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Figure 2.3 - Effects of control diet (CON) or control diet plus a yeast culture supplement
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck,
NJ) on relative abundance (%) of microbial species in rumen fluid in dairy cows during
the peripartal period until 50DIM. Values are means and the standard errors are
represented by vertical bars.
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Figure 2.4 - Effects of control diet (CON) or control diet plus a yeast culture supplement
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck,
NJ) on relative abundance (%) of microbial species in rumen fluid in dairy cows during
the peripartal period until 50DIM. Values are means and the standard errors are
represented by vertical bars.
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Figure 2.5 - Effects of control diet (CON) or control diet plus a yeast culture supplement
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck,
NJ) on blood NEFA (A) and BHB (B) in dairy cows during the transition period until
50DIM. Values are means and the standard errors are represented by vertical bars.
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CHAPTER 3. YEAST CULTURE SUPPLEMENTATION EFFECTS ON
SYSTEMIC AND POLYMORPHONUCLEAR LEUKOCYTES MRNA
BIOMARKERS OF INFLAMMATION AND LIVER FUNCTION IN
PERIPARTAL DAIRY COWS.

ABSTRACT
Feeding yeast culture additives has been attributed to health benefits during the
transition period of dairy cows. The objective of this study was to evaluate the effects of
feeding a commercial yeast culture on blood biomarkers of inflammation and liver
function, and gene expression in polymorphonuclear leukocytes (PMNL) in dairy cows
during the transition period until 50 d postpartum. Forty Holstein dairy cows were used in
a randomized complete block design from -30 to 50 d and blocked according to parity,
previous lactation milk yield, and genetic merit. At -30 d, cows were assigned to a basal
diet plus a top-dressed of either 114 g/d of ground corn (CON; n = 20) or 100 g/d of
ground corn and 14 g/d yeast culture product (YC; n = 20; Cellerate Culture Classic HD;
Phibro Animal Health, Teaneck, NJ). Cows received the same close-up diet from -30 to
calving (0.63 Mcal/kg DM and 12.3% CP) and lactation diet after calving (0.73 Mcal/kg
DM and 15.6% CP). Blood samples were collected at -30, -15, 7, 14, and 30 DIM to
evaluate liver function and inflammation biomarkers. Blood samples for PMNL gene
expression were collected at -30, -15, 5, 10, and 30 d. The mRNA in PMNL was analyzed
for genes associated with inflammation, cellular receptor, and oxidative stress. A trend for a
Diet × Time interaction was observed in GGT, where greater GGT was observed in YC
than CON cows at 30 d. Negative acute-phase proteins (APP), albumin, and paraoxonase
tended to be lower in YC than CON cows, while the positive APP, haptoglobin, tended to
be higher in YC than CON. In PMNL mRNA expression, the NFKB1 was upregulated in
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YC cows in comparison to CON. A trend for upregulation of TNFA, IL10, SELL, and
TLR2 was observed in cows supplemented with YC. The present study showed that yeast
culture supplementation might stimulate a mild inflammatory response in transition dairy
cows, based on blood biomarker and PMNL mRNA gene expression.
Key words: transition period, inflammation, yeast culture

INTRODUCTION
In dairy cows, the transition period is defined as 3 weeks before through 3 weeks
after parturition (Drackley, 1999), and it is the most critical period during the cow’s life.
The metabolic stress and altered immune function may contribute to the noticeable
incidence of health disorders in early lactation in dairy cows (Goff and Horst, 1997). The
development of nutritional-based strategies that can modulate an immune response will
positively affect dairy cows’ health. Yeast-based products have been used in livestock for
many years due to the beneficial effects on animals, with the most common species being
S. cerevisiae.
During the transition period, yeast-based products have been shown to improve
DMI (Dann et al., 2000; Shi et al., 2019) and milk yield (Nocek et al., 2011; Zaworski et
al., 2014), while others did not observe the same effects (Olagaray et al., 2019; Stefenoni
et al., 2020). Recent findings also suggest that yeast may influence immune function.
However, the mechanism behind the interaction between supplemented yeast and innate
immunity still unclear. According to Lopreiato et al. (2020), the responses can be
attributed to a better energy status promoted by positive effects on digestive function or
activation of the immune system by sensing yeast components.
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Jensen et al. (2008) demonstrate that yeast culture provides antioxidant, antiinflammatory, and immuno-modulatory activities in vitro. Yuan et al. (2015b) reported
that yeast culture plus enzymatically hydrolyzed yeast could enhance humoral and
mucosal immunity and modulated uterine inflammatory signals and mammary gland
health in transition dairy cows. Recently, Knoblock et al. (2019) evaluated the effects of
S. cerevisiae fermentation product in dairy cows fed diets with different starch content
during the early lactation and observed that yeast supplementation coupled with lowstarch diets might reduce inflammation. In lactating dairy cows, yeast cell wall
supplementation increased mRNA expression of cytokines in peripheral blood
mononuclear cells, which underscores yeast’s ability to mediate immune function (Aung
et al., 2020).
The objective of this study was to assess the effects of yeast-based products on
metabolism, inflammation, liver function, and immune function through blood
biomarkers and gene expression in PMNL in dairy cows during the transition period until
50 DIM.

MATERIAL AND METHODS
Animals, Experimental Design and Dietary Treatments
The Institutional Animal Care and Use Committee (IACUC) of the South Dakota
State University approved all the procedures for this study. Forty Holstein dairy cows
were used in a randomized complete block design and were blocked according to
lactation, calving date, and previous lactation milk yield. There were 6 primiparous and
34 multiparous enrolled in this study. Cows received the same close-up diet (1.32 Mcal of
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NEL/kg and 14.15% CP) 7 d prior to starting dietary treatments as an adaptation period.
Then, at -30 d before expected calving, cows were assigned to the treatments. The
treatments were top-dressed a control (CON; 114g/h/d ground corn; n = 20) or CON plus
yeast culture product (YC; 100g ground corn + 14g YC/h/d; n = 20). After parturition, all
cows were fed the lactation basal diet (1.72 Mcal of NEL/kg and 16.05% CP) as a total
mixed ration, and the supplementation continued through 50d postpartum.
The cows were enrolled in the experiment from mid-September 2018 to early
April 2019. Cows were feed using an individual gate system (American Calan,
Northwood, NH), and the intake of dry matter (DM) was recorded daily. Diets were
formulated using the NDS professional (Nutrition Dynamic System; RUMN Sas) to
meet the requirements of the average cow in the group according to the NRC (2001)
(Table 2.1). Dry matter of individual feed ingredients was determined weekly
accordingly, and diets were adjusted accordingly to maintain formulated DM ratios of
ingredients in the TMR. Cows were fed once daily at 0500 h before morning milking, and
feed offered was adjusted daily to achieve 5 to 10% refusals.
During the close-up period, the cows were housed in a bedded pack pen, and three
days before the expected calving date, the cows were reallocated in individual pens
bedded with straw until parturition. On day 3, after calving, cows were moved to a
lactation free-stall barn where they were receiving the same lactation basal diet until 50
DIM. Body weight was measured weekly for each cow at the same time in the afternoon.
Body condition score (BCS) (scale 1= thin to 5= obese) was assigned by two individuals,
and the average score was used for statistical analysis.
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Blood Collection and Analyses
Blood was sampled from the coccygeal vein before morning feeding using a 20gauge BD Vacutainer needle (Becton Dickinson, Franklin Lakes, NJ) at -30, -15, 7, 14,
and 30 d relative to parturition from a subset of cows (n=8 cows/treatment). Blood was
collected into Vacutainer (5 mL, BD Vacutainer, Becton Dickinson, Franklin Lakes, NJ)
containing either serum clot activator or lithium heparin. After collection, tubes
containing lithium heparin were placed on ice, and tubes with serum clot activator were
kept at 21°C until centrifugation. Serum and plasm were obtained by centrifugation at
1,300 × g for 15 min at 21°C and 4°C, respectively. The aliquots of plasma were frozen
at -80°C until further analysis.
Samples were analyzed for biomarkers of liver function [e.g., total bilirubin,
aspartate aminotransferase (AST/GOT), γ-glutamyl transpeptidase (GGT), cholesterol
and paraoxonase (PON)], inflammation [e.g., albumin, ceruloplasmin, haptoglobin and
interleukin 1β (IL-1β)], using kits purchased from Instrumentation Laboratory
(Lexington, MA) and the procedures were described by (Trevisi et al., 2012; Batistel et
al., 2016; Jacometo et al., 2016).
PMNL Isolation
Neutrophils were isolated based on procedures described by Osorio et al. (2013b).
Briefly, blood (~100 mL) was collected into evacuated tubes (8 mL, BD Vacutainer,
Becton Dickinson, Franklin Lakes, NJ) containing solution A of trisodium citrate citric
acid and dextrose (ACD) from the coccygeal vein prior to morning feeding at -30, 5, 15,
and 30 days relative to parturition from a subset of cows (n=8 cows/treatment). Tubes
were mixed by inversion immediately after collection and placed on ice (~4 °C) until
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isolation. Samples were centrifuged at 600 × g for 30 min at 4 °C. The plasma, buffy
coat, and approximately one-third of the red blood cells were discarded. The remaining
sample was poured into a 50-mL conical tube (Fisher Scientific, Pittsburgh, PA). Red
blood cells (RBC) were lysed with twenty-five milliliters of deionized water at 4 °C was
added into the tube, followed by the addition of 5 mL of 5 × PBS at 4 °C to restore an
iso-osmotic environment. Samples were centrifuged at 900 × g for 10 min at 4°C, and the
supernatants were decanted. The cell pellet was washed with 10 mL of 1 × PBS, and the
cell suspension was centrifuged at 900 × g for 5 min at 4°C, and the supernatants were
decanted. The remaining RBC were lysed with 8 mL of ice-cold deionized water,
homogenized gently by inversion and 2 mL of 5 × PBS at 4°C was added. The samples
were centrifuged at 900 × g for 5 min at 4°C, and the supernatant was discarded.
Subsequently, samples were washed twice using 10 mL of 1 × PBS at 4°C were
performed, followed by centrifugation 900 × g for 5 min at 4°C. The PMNL pellet was
homogenized with 1.5 mL of 1 × PBS at 4°C, transferred to a 2-mL RNase-DNase-free
microcentrifuge tube and centrifuged at 6,000 × g (Sorvall Legend Microcentrifuge 21R)
for 5 min at 4°C. The final PMNL pellet was homogenized in 1 mL of Trizol reagent
(Invitrogen, Carlsbad, CA) and stored at -80°C until further gene expression analysis.
RNA Isolation, cDNA Synthesis, and Real-Time Quantitative PCR
Total RNA was extracted from blood PMNL using Trizol (Invitrogen, Carlsbad,
CA) reagent in combination with the RNeasy® Plus Mini Kit (Qiagen, Hilden,
Germany), following the manufacturer’s instructions with some modifications. Briefly,
the cell pellet immersed in Trizol was transferred to a 2-mL RNase-free O-ring tube,
containing one stainless steel bead, 5 mm (Qiagen, Hilden, Germany) and homogenized
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in a Beadbeater (BioSpec Products, Bartlesville, OK) for 1 min. After homogenization,
the lysate was transferred to a 2-mL RNase-free microtube and 200 µL of
Phenol:chloroform (Invitrogen, Carlsbad, CA) at 4 °C was added in order to isolate the
RNA from the organic phase. After centrifugation at 13,000 × g for 15 min at 4 °C, the
upper phase supernatant was transferred into a new 2-mL RNase-free microtube. The
total RNA was purified using RNeasy® Plus Mini Kit and eluted in 50 µL of RNase-free
water. The RNA quantity for all PMNL samples was 327.17 ± 292.99 ng/µL and purity
(260/280) was 2.02 ± 0.10 determined using NanoDrop spectrophotometer (ND 1000,
NanoDrop Technologies Inc., Wilmington, DE).
RNA isolated from neutrophils was used for qPCR analysis. Complementary
DNA (cDNA) synthesis was performed according to Osorio et al. (2013a) with
modifications. cDNA was synthesized using 100 ng RNA, 1 µL random primers
(Invitrogen Corp., CA), and 9 µL DNase/RNase free water (HyClone, UltraPure™). The
mixture was incubated at 65 °C for 5 min and kept on ice for 5 min. A total of 9 µL of
master mix composed of 4 µL 5X Reaction Buffer, 1 µg dT18 (Operon Biotechnologies,
AL), 2 µL 10 mmol/L dNTP mix (Invitrogen Corp., CA), 0.25 µL (50 U) of
RevertAidTM Reverse Transcriptase (Fermentas Inc., MD), 0.125 µL of RNase Inhibitor
(10 U, Promega, WI), and 1.625 µL of DNase/RNase free water (HyClone, UltraPure™)
was added. The reaction was performed in an Eppendorf Mastercycler® Gradient using
the following temperature program: 25 °C for 5 min, 42 °C for 120 min and 70 °C for 5
min.
The cDNA was diluted 1:4 with RNase-free water (HyClone, UltraPure™). The
quantitative PCR was performed in a MicroAmp Optical 384-Well Reaction Plate
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(Applied Biosystems, Grand Island, NY). In each well, 4µL diluted cDNA combined
with 6 µL of a mixture composed of 5 µL 1 × SYBR Green master mix (Applied
Biosystems, CA), 0.4 µL each of 10 µM forward and reverse primers, and 0.2 µL
DNase/RNase free water (HyClone, UltraPure™). Samples were run in triplicate, and a
6-point relative standard curve plus a non-template control were used. The reaction was
performed in QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems,
Walthan, MA) following the conditions: 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s
at 95°C (denaturation) and 1 min at 60°C (annealing + extension). A dissociation curve
was performed (gradient from 95°C to 60°C to 95°C for 15s) to check the amplicon
quality.
Primers sequence information and sources can be found in Table 3.1. In this
study, the genes Golgin A5 (GOLGA5), Oxysterol Binding Protein Like 2 (OSBPL2), and
Single-Strand-Selective Monofunctional Uracil-DNA Glycosylase 1 (SMUG1) were used
as internal control genes (ICGs) as described by Moyes et al. (2010). The final gene
expression data were normalized with the geometric mean of the 3 internal control genes.
The stability of the ICG was assessed using the geNorm software (Vandesompele et al.,
2002) with a favorable final pairwise variation of 0.17.
Target genes measured are described in Table 3.2, and these were related to
inflammation [tumor necrosis factor alpha (TNFA), nuclear factor of kappa light
polypeptide gene enhancer in B-cells 1 (NFKB1), interleukin 1B (IL1B) and interleukin
10 (IL10), interleukin 6 (IL6)] and cell receptors [toll like receptor 2 (TLR2), toll-like
receptor 4 (TLR4), selectin-L (SELL) and interleukin 1 receptor associated kinase 1
(IRAK1)].
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Statistical Analysis
Blood biomarkers and gene expression data were analyzed using the MIXED
procedure of SAS 9.4 (SAS Institute Inc., Cary, NC) using diet, time (day or week), and
their interactions as fixed effects and cow nested within treatment as a random effect.
Parity effect was removed from the model any time it was nonsignificant (P > 0.05).
The exponential correlation covariance structure SP for repeated measures was
used for the analysis of gene expression and blood biomarkers data with the following
model:
𝑦𝑖𝑗𝑘 = 𝜇 + 𝐷𝑖 + 𝑇𝑗 + 𝐷𝑇𝑖𝑗 + 𝛼𝑘 + 𝑒𝑖𝑗𝑘
where yijk is the dependent, continuous variable; μ is the general mean; Di is the fixed
effect of the diet (i =1 or 2, namely, CON or YC); Tj is the fixed effect of the time (j = 1,
2, 3 or 4, namely, -30, 5, 15, and 30 DIM); DTij is the fixed effect of ith treatment by jth
time of the interaction.; αk is the random effect of cow; eijk is the random residual.
Blood metabolites data were log-scale transformed if needed to comply with
normal distribution of residuals and subsequently back-transformed. Gene expression
data were log-transformed prior to statistical analysis. Data on day -30 was used as a
covariate for all the analyses. The covariate of previous 305-d milk yield was maintained
in the model for all variables for which it was significant (P < 0.05). Statistical
significance was declared at P ≤ 0.05 and tendencies at P < 0.15.
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RESULTS
Blood Biomarkers
Main effects of diet, time, and their interactions for blood metabolites associated
with liver function and inflammation are presented in Table 3.3 and Figure 3.1. There
was a trend (P= 0.07) for a D × T in GGT, which resulted in greater concentrations of
GGT in YC fed cows than CON at 30 DIM (P < 0.01), and this effect was reflected in an
overall greater (P = 0.03) GGT in YC cows. Similar to GGT, haptoglobin tended (P =
0.12) to be greater in YC cows in comparison to CON. In contrast to GGT and
haptoglobin, there was a trend for lower PON (P = 0.12) and albumin (P = 0.06) in YC
fed cows when compared to CON. Total bilirubin, GOT, cholesterol, ceruloplasmin and
IL-1β were not affected by diet, time, or their interactions.
Gene Expression
Main effects of diet, time, and their interactions for PMNL mRNA gene
expression are present in Table 3.4 and Figure 3.2. There was a trend (P = 0.11) for an
upregulation of TNFA in YC cows than CON cows. The mRNA expression of NFKB1
was greater (P = 0.04) in YC than CON cows. Similar to TNFA, there was a tendency for
greater (P = 0.07) mRNA expression of IL10 in cows supplemented with YC than CON
(Figure 3.2). There was a trend (P = 0.11) for an upregulation of SELL in YC fed cows in
comparison to CON (Figure 3.2). Similar to SELL, there was a trend (P = 0.14) for a
greater expression of TRL2 in YC than CON group. The expression of IL1B, TLR4, and
IRAK1 was not affected by diet, time, or their interaction.
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DISCUSSION
Effects on performance parameters, blood biomarkers (i.e., muscle body mass,
metabolism, and oxidative stress) and rumen fermentation and bacteria populations for
this study have been evaluated in a companion manuscript. In summary, we observed a
trend for a diet effect in milk yield, where YC cows (36.8 ± 1.15 kg/d) produced 2.5 kg/d
more milk than CON cows (34.3 ± 1.15 kg/d). The latter was reflected in a trend for
greater energy corrected milk (ECM) and milk fat yield in YC cows than CON. Yeast
culture supplementation also promoted alterations in rumen fermentation, increasing
valerate by optimizing the abundance of cellulolytic and lactate-utilizing bacteria. The
current companion manuscript focused on systemic and PMNL mRNA indicators of
inflammation and liver function during the transition period of dairy cows supplemented
with a yeast culture.
Inflammation
During the transition period, dairy cows are more susceptible to health disorders
such as mastitis, ketosis, retained placenta, metritis, and displaced abomasum. A common
factor associated with the development of these disorders is the immune dysfunction
(Sordillo, 2016), which, in turn, is caused by metabolic changes during the transition
period.
Inflammation is a component of the immune response that involves physiological
and pathological responses that helps the body adapt or eliminate an adverse stimulus to
return tissues to normal function or homeostasis (Bradford et al., 2015; Sordillo, 2016).
The most common event to occur during the inflammation is a systemic or acute phase
response (APR). The primary stimulators of the APR are the pro-inflammatory cytokines,

78

including TNFα, IL1β, and IL6 (Gauldie et al., 1987). These cytokines can activate
leukocytes and endothelial cells (Bannerman et al., 2009) and alter the normal protein
synthesis in hepatocytes. These proteins for which their hepatic synthesis is altered
during APR are called acute phase proteins (APP). According to Ceciliani et al. (2012),
during the acute phase response, the concentration of APP change dramatically, and
because of this, they were classified as positive (increase) or negative (decrease) APP.
The most common positive APP are serum amyloid A, haptoglobin, and ceruloplasmin,
and the negative APP include albumin, PON, and apolipoproteins.
During the transition period, alterations in APP have been used to monitor
inflammation and liver function (Trevisi et al., 2010). In a retrospective analysis, Bertoni
et al. (2008) classified early lactation dairy cows according to a liver activity index (LAI)
and evaluated APP concentrations based on this classification. The albumin levels from
cows classified as a high LAI was 34.5 g/L, while low LAI cows had 29.0 g/L. In the
current study, albumin reached nadir levels at 7 DIM, regardless of treatment, at which
point the albumin levels in YC and CON cows were 34.4 and 35.6 g/L, respectively.
These data indicate that while YC cows tended (P = 0.06) have lower albumin
concentration than CON, this was comparable to that in cows classified with a high LAI
in Bertoni et al. (2008). The levels of albumin are constant during the pregnancy (35-36
g/L) followed by a reduction soon after calving and returning to prepartal levels (36-37
g/L) as cows progress into their lactation (Bertoni and Trevisi, 2013). The same effect
was observed in our study. The latter suggests that it is less likely that YC cows were
under a significant inflammation level, and perhaps the impact on liver function was
minimal.
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The positive APP, haptoglobin, has been observed to increase during stress
periods promoting an APR; therefore, low LAI cows have been observed to have greater
haptoglobin than high LAI cows (Bertoni et al., 2008). The trend for overall greater
haptoglobin in YC cows than CON seems to be driven by the greater haptoglobin in YC
cows at 7 and 14 DIM (Figure 3.1). However, the maximal haptoglobin ca. 0.32 g/L in
YC cows at 7 DIM reached similar levels than cows classified as high LAI (0.3 g/L) at 7
DIM (Bertoni et al., 2008). After 7 DIM, YC cows presented an evident decline in
haptoglobin, similar to that observed in Bertoni et al. (2008). Maximal haptoglobin
commonly occurs within the first week postpartum. For instance, at 7 DIM, a ~0.8 g/L
haptoglobin concentrations have been reported (Bertoni and Trevisi, 2013). Our data
suggest that YC cows experienced a mild activation of the immune system that was
transient as this group of cows did not present common inflammation patterns of low
albumin coupled with high haptoglobin. In contrast to our results, yeast supplementation
tended to reduce haptoglobin levels in different conditions (Dias et al., 2018; Perdomo et
al., 2020). For instance, under heat stress, early lactation dairy cows supplemented with
up to 1g the dose of live yeast tended to reduce haptoglobin (Perdomo et al., 2020). Dias
et al. (2018) evaluated the effects of a culture of S. cerevisiae in lactating dairy cows fed
diets with varying starch content. The supplementation of yeast culture attenuated the
inflammatory stimulus, tended to reduce the concentration of haptoglobin in high-starch
diets. The authors further discussed that yeast can minimized the risk of cows developing
subacute ruminal acidosis and systemic inflammation because of the translocation of
inflammatory mediators from rumen to blood. However, the yeast effect attenuating
inflammation can be due the conditions that the lactating dairy cows were subjected to,

80

like heat stress or high-starch diets. In transition cows, due to the metabolic changes
associated to NEB, the haptoglobin levels can vary more, especially post-calving.
Liver Function
The low levels of PON during the early postpartum period in dairy cows have
been associated with metabolic disorders such as excessive fat mobilization and
triglyceride accumulation (Turk et al., 2004). Bionaz et al. (2007) performed a
retrospective analysis by classifying cows based on their blood PON concentration with
the aim to test the feasibility of using this metabolite as a marker for liver function. The
overall PON values for cows classified as high PON activity group were 92 U/mL, and
PON concentration increased significantly in this group during the first 2wk of lactation.
In our study, the PON levels for YC (95.0 U/mL) and CON (102.5 U/mL) cows were
greater than those reported by Bionaz et al. (2007), followed by an increase postpartum.
Similar to albumin, the lowest PON levels in YC cows were observed at 7 DIM (Figure
3.1); however, this PON level in YC cows was similar to that in cows designated as high
PON activity group in Bionaz et al. (2007). Our results suggest that both YC and CON
cows were at a greater level of PON, indicating that cows were not in an inflammatory
condition. During inflammatory conditions, negative APP, such as PON, albumin,
lipoproteins and retinol-binding protein, typically decrease (Bionaz and Loor, 2007;
Trevisi et al., 2012). The reduction of PON observed at 7 DIM in YC cows can happen in
transition dairy cows due to a reduction in liver-derived HDL, which plays an important
role in PON’s availability in circulation, particularly before calving (Bionaz et al., 2007).
Our study is limited in that we cannot ascribe the observed effect in liver-derived HDL
because we did not measure this metabolite.
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The GGT is a membrane-associated enzyme involved in hepatic AA metabolism,
and its plasma concentration has been associated with liver cell damage (Bionaz et al.,
2007). In the current study, we observed an increase in GGT in YC cows, and this effect
was more pronounced at 30 DIM, where GGT levels for YC cows were 94.9 U/L. Bertoni
et al. (2008) showed that GGT levels were not different across different LAI-based
groups, suggesting that LAI does not account for liver cell damage. According to Trevisi
et al., (2001), impaired liver function is not equal to lower liver activity due to liver
damaged, but rather a diverted synthesis of proteins (i.e., APP) during inflammation.
Although we can conclude that YC cows had greater GGT than CON by 30 DIM, these
levels did not surpass those observed in Bertoni et al. (2008), which indicates that YC
cows in the current study were less prone to develop liver cell damage. Our results are
also in agreement with others, where transition dairy cows presented high concentrations
of GGT at 30DIM (Rodriguez-Jimenez et al., 2018; Mezzetti et al., 2019). Other authors
have reported the effects of yeast supplementation in GGT levels in dairy cows (Al
Ibrahim et al., 2010; Aung et al., 2019). In lactating dairy cows, yeast cell wall
supplementation did not affect the GGT concentration, but the levels (27.38 U/L) were
higher than those observed in our study (Aung et al., 2019). Live yeast supplementation
did not affect the GGT levels in early lactating dairy cows; however, the concentration
(10.36 U/L) was lower than we observed in this study (Al Ibrahim et al., 2010). Taken
together, our results suggest that YC cows were in a mild inflammatory condition,
meaning that inflammation was not enough to cause negative effects on liver activity.
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Gene Expression
The immune system relies on the innate immune system components to detect and
mount an early response to infectious microorganisms. In the cell surface of immune
cells, there are receptors known as pattern recognition receptors that recognize two
classes of molecules: pathogen-associated molecular patterns, associated with pathogens
products, and damage-associated molecular patterns, which are related to components of
host's cells that are released during cell damage or death (Sordillo, 2016). When
activated, these receptors initiate a signal transduction pathway that results in gene
transcription and activation of pro-inflammatory cytokines, playing an important role in
triggering and regulating the immune responses (Lee and Hwang, 2006).
The antioxidant, anti-inflammatory, and immunomodulatory properties of yeast
culture have been demonstrated in vitro. Such characteristics can mediate interactions
between different immune cell populations, including neutrophils, monocytes, dendritic
cells, B cells, T cells, and natural killer cells (Jensen et al., 2008). In the same study,
Jensen et al. (2008) indicated that the mode of action of yeast culture remains unknown;
however, this could be partially supported by an initial cellular interaction in gut mucosal
tissue, resulting in changes in blood metabolites and cytokine profile. In our study, we
observed that yeast culture altered blood biomarkers related to inflammation and liver
function, and gene expression in PMNL, suggesting a cellular interaction between
immune cells and yeast.
The immunomodulatory effects of yeast have been reported on genes related to
inflammation across different species (Zanello et al., 2011; Yuan et al., 2015b; Adeyemi
et al., 2019). Zanello et al. (2011) showed that S. cerevisiae (strain CNCM I-3856) exerts
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an immunomodulatory effect in porcine intestinal epithelial cells, activating genes related
to inflammation. In weaning pigs supplemented with S. cerevisiae fermentation products,
Weedman et al. (2011) reported an upregulation of TLR2 and TLR4 in mesenteric lymph
nodes on 1 d after weaning, suggesting that yeast culture had primed immune cells for the
changes that occur during the weaning period. In transition dairy cows, Yuan et al.
(2015b) reported that yeast culture plus enzymatically hydrolyzed yeast magnified
humoral and mucosal immunity, causing an overall improvement in uterine and
mammary gland health. In newly weaned beef steers, supplementation with S. cerevisiaebased product was attributed with upregulating gene networks responsible for promoting
the animal’s immune response to pathogens (Adeyemi et al., 2019).
To the best of our knowledge, there are no published data evaluating gene
expression in bovine PMNL responsiveness of yeast culture supplementation. In the
current study, we observed that NFKB1, TNFA, and TLR2 were upregulated to a lesser
extent. The NFKB1 is a transcription factor associated with inflammation. An
inflammatory response commonly causes an upregulation of NFKB1, which, in turn,
upregulates cytokines such as TNFA and IL10, as well as several other genes related to
inflammation (Trevisi et al., 2011; Moyes et al., 2014). The upregulation of NFKB1 in
cows supplemented with YC can be associated with increased blood biomarkers related
to inflammation and liver function, previously discussed. The effects on blood
metabolites indicating mild inflammatory condition in YC cows could be reflected in the
upregulation of NFKB1 and, consequently, activation of other cytokines. Due to S.
cerevisiae-based supplementation, Adeyemi et al. (2019) observed an upregulation of
genes involved in the immune response, such as TNFA and TLR2 detected in whole-blood

84

RNA gene expression. In mice, yeast cell wall supplementation induced a release of
proinflammatory cytokines, such as TNFA (Walachowski et al., 2016), similar to our
findings.
Neutrophils are targeted by IL-10, a cytokine commonly associated with the
resolution of the inflammation (Moore et al., 2001; Bazzoni et al., 2010). This cytokine
expression has been reported in transition dairy cows in different conditions (Zhou et al.,
2015; Batistel et al., 2017). Transition dairy cows fed with a prepartal high-energy diet
upregulated the anti-inflammatory IL10 in PMNL, and such upregulation was found at
−14 and 7 DIM (Zhou et al., 2015). In our study, an upregulation of proinflammatory
cytokines was observed in YC cows, coupled with the upregulation of IL10. The
production of proinflammatory cytokines is inhibited by IL-10, which helps to limit the
duration and pathology of inflammatory responses (Moore et al., 2001). Yeast improving
the production of anti-inflammatory cytokines in transition dairy cows may indicate a
pivotal effect of this feed supplement by activating the immune response aiding on the
resolution of inflammation since cows experience an immune dysfunction during this
period. The alterations of immunity in transition dairy cows, mainly after parturition, can
be exacerbated by metabolic disorders (Sordillo, 2016).
In a recent study, Aung et al. (2020) isolated peripheral blood mononuclear cells
from lactating dairy cows supplemented with yeast cell wall and observed that
supplementation increased the leukocyte population and upregulated IL8 and IL12 in
mononuclear cells, which might enhance the cellular immune function. The actual
mechanism that yeast uses to stimulate an inflammatory response in ruminants still
unclear, but the yeast cell wall fraction, medium used to grow the yeast, and yeast species
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will likely play a fundamental role in this mechanism. In non-ruminants, β-glucan
fragments present in the yeast cell wall have been suggested to stimulate the immune
system (Alugongo et al., 2017). The Dectin-1 pathway is the most studied initial
interaction of dietary β-glucans with the immune system, and the signaling cascade
results in upregulation of TNFA and interleukins (e.g., IL-2, IL-10, IL-12, and IL-4), as
well as the production of reactive oxygen species (ROS) (Willcocks et al., 2006). We did
not evaluate the Dectin-1 pathway in our study; however, it would be interesting looking
at this pathway in further studies.
The SELL gene encodes the L-selectin protein expressed in the cell surface of
PMNL that mediates its initial attachment to inflammation sites in the endothelium
(Paape et al., 2003). The L-selectin facilitates the interaction between leukocytes and
endothelial cells to start the process called “rolling” (Raffler et al., 2005). After rolling,
the PMNL binds to additional endothelial receptors such as intercellular adhesion
molecule (ICAM), making tighter attachments between PMNL and endothelium. In the
current study, we observed a trend for an upregulation of SELL in YC cows, meaning that
the neutrophils might be stimulated due to yeast culture supplementation.
Based on gene expression results, it is plausible that yeast culture supplementation
elicits an immune response in transition dairy cows. This is based on PMNL in YC cows
being more stimulated than CON, suggesting that YC cows were exposed to an
inflammatory stimulus. We can assume that yeast cell wall fragments such as β-glucans
can bypass ruminal fermentation and promote PMNL gene expression alterations in the
lower gastrointestinal tract. The exact mechanism that yeast may use to escape ruminal
fermentation and interact with immune cells still inconclusive. We can also speculate that
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β-glucans fragments can interact with membrane receptors in the ruminal epithelium,
promoting the recruitment of immune cells and, in consequence, an immune response.

CONCLUSIONS
Supplementation of yeast culture derived from S. cerevisiae has been examined
for many years to improve performance and health in dairy cows. In transition dairy
cows, it is well known that the immune system is compromised, and this type of
supplementation can be helpful during this challenging period. The present study showed
that yeast supplementation might stimulate a mild inflammatory response in transition
dairy cows, based on blood biomarker and PMNL mRNA expression. This can be
associated with a natural response to yeast cell wall components, such as β-glucans, that
can activate the immune system. In a companion paper, we reported the effects of yeast
supplementation on performance, and we conclude that mild inflammatory conditions in
YC did not cause a negative effect on DMI and milk yield. This result confirms that yeast
culture could stimulate the immune system in transition dairy cows and promote a
pronounced immune response against pathogen infection.
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Table 3.1 - GenBank accession number, hybridization position, sequence and amplicon
size of primers for Bos taurus used to analyze gene expression by qPCR.
Symbol

Primers

Primers (5’-3’)

EU276074.1

IL10

NM_174093.1

IL1B

F.171
R.268
F.453
R.552
F.950
R.1052
F.172
R.266
F.588
R.691
F.1201
R.1302
F.102
R.203
F.438
R.537

GAAGGACCAACTGCACAGCTT
AAAACTGGATCATTTCCGACAAG
TCCACCTCCTCTCACAGGAAA
TACCCAAGGCCACAGGAA
CCTCAGCGACTGGACATCCT
GGACGTTGGAACTCTTGACATCT
TCAACCGGAGATGCCACTAC
ACACACGTAACGGAAACGAAATC
CTCTGCTACACAGCTTCTTGTAAACC
CCGTAGTACCCCAAATCACAGTT
AAGAGTCACAATAGAAAG
GCTATTTATGACACATCCAA
GCTGTTTGACCAGTCTGATTGC
GGGCTGAAGTAACAACAAGAGGAA
TCTCAAGCCTCAAGTAACAAGCC
CCATGAGGGCATTGGCATAC

Accession no.

NM_001040555.1

IRAK1

NM_001076409.1

NFKB1

NM_174182.1

SELL

NM_174197.2

TLR2

NM_174198.6

TLR4

EU276079.1

TNFα

Amplicon size
(bp)
98
100
103
95
104
102
102
100
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Table 3.2 - Genes selected for transcript profiling in bovine PMNL.
Gene Name

Symbol

Interleukin 10

IL10

Interleukin 1 B

IL1B

Interleukin 1 Receptor
Associated Kinase 1
IRAK1

Nuclear Factor Of Kappa
Light Polypeptide Gene
Enhancer In B-Cells 1

Selectin-L

Toll-like receptor 2

NF-KB1

SELL

TLR2

Toll-like receptor 4
TLR4

Tumor Necrosis Factor
Alpha

TNFα

Function
Inhibits the synthesis of a number of cytokines,
including IFN-gamma, IL-2, IL-3, TNF and GM-CSF
produced by activated macrophages and by helper Tcells.
Produced by activated macrophages, IL-1 stimulates
thymocyte proliferation by inducing IL-2 release, Bcell maturation and proliferation, and fibroblast
growth factor activity. Potent pro-inflammatory
cytokine.
This gene encodes the interleukin-1 receptorassociated kinase 1, one of two putative
serine/threonine kinases that become associated with
the interleukin-1 receptor (IL1R) upon stimulation.
This gene is partially responsible for IL1-induced
upregulation of the transcription factor NF-kappa B.
Involved in Toll-like receptor (TLR) and IL-1R
signaling pathways. Is rapidly recruited by MYD88 to
the receptor-signaling complex upon TLR activation.
NF-kappa-B is a pleiotropic transcription factor
present in almost all cell types and is the endpoint of a
series of signal transduction events that are initiated by
a vast array of stimuli related to many biological
processes such as inflammation, immunity,
differentiation, cell growth, tumorigenesis, and
apoptosis.
Mediates the adherence of lymphocytes to endothelial
cells of high endothelial venules in peripheral lymph
nodes. Promotes initial tethering and rolling of
leukocytes in endothelia.
The protein encoded by this gene is a member of the
Toll-like receptor (TLR) family which plays a
fundamental role in pathogen recognition and
activation of innate immunity.
The protein encoded by this gene is a member of the
Toll-like receptor (TLR) family which plays a
fundamental role in pathogen recognition and
activation of innate immunity. This receptor has been
implicated in signal transduction events induced by
LPS found in most gram-negative bacteria. Mutations
in this gene have been associated with differences in
LPS responsiveness
Secreted by macrophages and can induce cell death of
certain tumor cell lines. It is potent pyrogen causing
fever by direct action or by stimulation of interleukin1 secretion and is implicated in the induction of
cachexia, under certain conditions it can stimulate cell
proliferation and induce cell differentiation.
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Table 3.3 - Effects of supplementing cows with a control diet (CON) or control diet plus
a yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro
Animal Health, Teaneck, NJ) in blood biomarkers related to liver function and
inflammation in peripartal dairy cows until 50DIM.
Parameter
Liver function
Total bilirubin, µmol/L2
GOT, U/L
GGT, U/L2
Cholesterol, mmol/L
Paraoxonase, U/mL
Inflammation
Albumin, g/L
Ceruloplasmin, µmol/L
Haptoglobin, g/L2
IL-1β, pg/mL2
1Largest

Treatment
CON
YC

SEM

1

Diet

P-value
Time
D × T3

1.88
93.3
18.3
3.72
102.5

1.98
94.6
20.3
3.53
95.0

0.28
3.99
0.04
0.11
3.4

0.81
0.81
0.03
0.25
0.12

< 0.01
< 0.01
< 0.01
< 0.01
< 0.01

0.70
0.72
0.07
0.96
0.21

35.6
2.44
0.28
32.3

34.4
2.48
0.36
31.2

0.40
0.06
0.15
0.21

0.06
0.69
0.12
0.86

< 0.01
0.03
0.09
< 0.01

0.54
0.15
0.59
0.17

standard error of the mean is shown.
were log-transformed before statistics. The standard errors of the means associated with log-transformed data are
in log scale.
3Interaction of treatment and days in milk.
2Data
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Table 3.4 - Effects of supplementing cows with a control diet (CON) or control diet plus
a yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro
Animal Health, Teaneck, NJ) in PMNL mRNA gene expression in peripartal dairy cows
until 50DIM.
1

Gene
Inflammation
TNFA
NFKB1
IL1B
IL10
Cell receptors and signaling
TLR2
TLR4
SELL
IRAK1
1Fold

Treatment
CON
YC

Diet

P-value
Time
D × T3

1.41
0.99
3.24
1.15

2.34
1.17
2.32
2.19

1.22
0.23
1.69
1.13

0.11
0.04
0.32
0.07

< 0.01
0.33
0.28
< 0.01

0.16
0.42
0.62
0.17

1.14
0.94
0.93
1.07

1.40
1.11
1.22
1.20

0.48
0.15
0.29
0.25

0.14
0.33
0.11
0.36

0.05
0.82
0.80
0.24

0.44
0.45
0.53
0.73

change data were log-transformed before statistics
standard error of the mean is shown.
3Interaction of treatment and days in milk.
2Largest

SEM

2
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5.0

140

A
*

4.4
4.2
4.0

0.0

Diet, P = 0.06
Time, P <0.01
Diet x Time, P = 0.54

C
Log2 (Haptoglobin, g/L)

Albumin (g/L)

Diet, P = 0.12
Time, P = 0.09
Diet x Time, P = 0.59

D

100

60

3.6

38

B

80

CON
YC

3.8

40

Diet, P = 0.12
Time, P <0.01
Diet x Time, P = 0.21

120

4.6
PON (U/mL)

Log 2 (GGT, U/L)

4.8

Diet, P = 0.03
Time, P <0.01
Diet x Time, P = 0.07

36
34
32
30

-0.5
-1.0
-1.5
-2.0
-2.5
-3.0

-30

-15
7 14
Day relative to parturition

30

-30

-15
7 14
Day relative to parturition

30

Figure 3.1 - Effects of control diet (CON) or control diet plus a yeast culture supplement
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck,
NJ) on blood GGT (A), Paraoxonase (B), Albumin (C) and Haptoglobin (D) in peripartal
dairy cows until 50DIM. Values are means and the standard errors are represented by
vertical bars. The P-values for main effect of diet (D) and time (T) and D × T are shown.
Significant differences between D x T (P < 0.10) are denoted by an asterisk.
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2

1.0

1
0
CON
YC

-1

1.2

A

Diet, P = 0.07
Time, P < 0.01
Diet x Time, P = 0.17

Fold change (SELL)

Fold change (IL10)

3

B

Diet, P = 0.11
Time, P = 0.80
Diet x Time, P = 0.53

0.8
0.6
0.4
0.2
0.0
-0.2
-0.4
-0.6

-2
-30

5
15
30
Days relative to parturition

-30

5
15
Days relative to parturition

Figure 3.2 - Expression of genes associated to inflammation (A) and cell receptor and
signaling (B) in PMNL in dairy cows fed with control diet (CON) or control diet plus a
yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro
Animal Health, Teaneck, NJ) in peripartal dairy cows until 50DIM. Data are from -30d
(prepartum), 5d, 15d and 30d (postpartum). The P-values for main effect of diet (D) and
time (T) and D × T are shown.

Days relative to parturition

Days relative to parturition

30
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